catechin has been researched along with Disease Models, Animal in 463 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.22) | 18.7374 |
1990's | 8 (1.73) | 18.2507 |
2000's | 79 (17.06) | 29.6817 |
2010's | 292 (63.07) | 24.3611 |
2020's | 83 (17.93) | 2.80 |
Authors | Studies |
---|---|
Cuendet, M; Fong, HH; Hawthorne, ME; Kardono, LB; Kinghorn, AD; Mehta, RG; Pezzuto, JM; Riswan, S; Su, BN | 1 |
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Guo, N; Hao, K; Liu, C; Liu, Z | 1 |
Hirai, C; Kan, T; Kurokawa, A; Masuda, S; Noaki, R; Shimamura, Y; Utsumi, M | 1 |
Cui, Y; Liu, G; Wang, Y | 1 |
Jang, S; Kim, HJ; Kim, T; Park, SH; Song, HK | 1 |
Chen, JX; He, YL; Lin, WT; Wei, X; Xu, WX; Zeng, M | 1 |
Ceballos, G; Cedeño-Garcidueñas, AL; Espinosa-Raya, J; Garate-Carrillo, A; Gomez-Diaz, B; Lara-Hernandez, M; Moreno-Ulloa, A; Navarrete-Yañez, V; Ramirez-Sanchez, I; Villarreal, F | 1 |
Han, X; Huang, L; Luo, X; Mao, Q; Peng, C; Wu, S; Zhang, H | 1 |
Jang, M; Jung, W; Park, J; Park, R; Park, Y; Park, YI | 1 |
Liu, L; Luo, M; Mou, Q; Tian, J | 1 |
Chen, Q; Huang, L; Jiao, W; Liu, S; Liu, W; Zhang, C; Zhang, Y; Zhao, T; Zhong, S | 1 |
Chen, S; He, P; Li, B; Tu, Y; Wang, K; Wu, J; Zhao, H | 1 |
Huang, X; Jia, Z; Liu, L; Luo, M; Mou, Q; Quan, J; Tian, J | 1 |
Cao, Y; Liu, S; Ma, L; Ma, Y; Ramos-Mucci, L; Sun, J; Xiao, B; Yang, X; Zhang, J; Zhu, Z | 1 |
Chang, HW; Chen, LC; Cheng, TC; Fang, CL; Ho, YS; Kuo, CC; Lee, WJ; Liao, YC; Lin, LC; Tu, SH; Yen, Y | 1 |
Abdel-Moneim, AM; Abdelmeguid, NE; Hammad, TM; Salam, SA | 1 |
Akhtar, MF; Bukhari, SA; Mubeen, A; Najda, A; Saleem, A; Zeb, A | 1 |
Cremonini, E; Kang, J; Le Gall, G; Muller, M; Oteiza, PI; Pontifex, MG; Vauzour, D; Wang, Z | 1 |
Chen, SM; Li, WJ; Luo, YP; Tang, XF; Wu, Q; Zhang, YC | 1 |
Callaerts-Vegh, Z; González-Colom, R; Llambrich, S; Martínez-Abadías, N; Roldán, J; Salassa, S; Sharpe, J; Van Bulck, V; Vande Velde, G; Wouters, J; Wouters, K | 1 |
Bae, KH; Chan, KH; Chen, Q; Her, Z; Kurisawa, M; Lai, F; Mong, J; Niibori-Nambu, A; Osato, M; Tan, MH | 1 |
Chen, H; Guo, J; Jin, S; Qin, T; Yao, D | 1 |
Chen, L; Gan, X; Jian, J; Liang, R; Wang, R; Yu, Q; Zhang, N | 1 |
Chakkittukandiyil, A; Kothandan, R; Rymbai, E; Selvaraj, D; Selvaraj, J; Sugumar, D | 1 |
Ding, Q; Fang, R; Qin, P; Wang, X; Wu, H; Xu, F; Yu, P; Zhang, M | 1 |
Chen, MH; Fang, W; Li, N; Qin, S; Qin, T; Tan, XF; Xie, L; Yang, YG | 1 |
Gao, B; Guo, ZW; Li, YQ; Lu, MD; Wang, ZY; Xue, TC; Zhou, XH | 1 |
Chen, X; He, K; Huang, X; Liu, J; Nie, L; Spencer, P; Xu, B; Yang, X; Zhou, L | 1 |
Hochstetter, D; Mao, L; Wang, Y; Xu, P; Yao, L; Zhao, Y; Zhou, J | 1 |
Dagli, AF; Gencoglu, H; Karatas, A; Koca, SS; Orhan, C; Ozgen, M; Sahin, K; Sahin, N | 1 |
Dong, R; Wang, J; Wang, X; Wu, X; Yang, CS; Yang, L; Zhang, J; Zhang, Y; Zhang, Z | 1 |
Chen, L; Gan, X; Jian, J; Liang, R; Yang, X; Zhang, C | 1 |
Chang, KC; Fang, CH; Li, KY; Lin, YW; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH; Yang, CC | 1 |
Aral, M; Ergün, Y; Hedef, A; Kaya, E; Kılınç, M | 1 |
Bang, IJ; Chung, KH; Jeong, MH; Kim, DM; Kim, HR; Kim, KH; Kwon, SH; Park, YJ; So, HM; Yu, JS | 1 |
Gao, Q; Granato, D; Hu, L; Kan, Z; Li, X; Peng, CY; Qian, F; Wang, D; Wang, T; Wang, Y | 1 |
Ceballos, G; Hidalgo, I; Meaney, E; Nájera, N; Pérez-Durán, J; Valdespino-Vazquez, Y; Villarreal, F | 1 |
Gao, H; Li, M; Wu, Y; Xiao, Y; Zhong, K | 1 |
Dhir, A | 1 |
Cui, J; Wu, Y | 1 |
Hu, Y; Hu, Z; Huang, S; Liu, H; Shang, P; Tang, Q; Zhu, J | 1 |
Chang, WL; Clapper, ML; Cooper, HS | 1 |
Li, Y; Wang, HL; Xiang, L; Xiao, G; Xiao, J; Xie, M; Xu, Y; Xue, J | 1 |
Bao, J; Gui, YR; Liu, W; Long, GF; Shang, JT; Shu, XJ; Wu, MJ; Xiao, YF; Yang, YH; Zhou, HY | 1 |
Chen, X; Ji, X; Li, J; Liu, S; Luo, D; Ma, X; Xu, J; Xu, X; Zhao, J; Zhu, X | 1 |
Kang, JB; Koh, PO; Park, DJ | 2 |
Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y | 1 |
Barroso, PA; Bracamonte, E; Korenaga, M; Marco, JD; Moya Álvarez, A; Sosa, AM | 1 |
Bae, HJ; Cai, M; Cho, K; Goo, N; Jeon, SJ; Jeong, Y; Jung, SY; Kim, J; Kwon, KJ; Ryu, JH | 1 |
Alemany-González, M; Dierssen, M; Gener, T; Nebot, P; Puig, MV; Vilademunt, M | 1 |
Kang, J; Oteiza, PI; Wang, Z | 1 |
Berry, DL; Cheema, A; Chung, FL; Coia, H; Cruz, MI; Girgis, M; Hou, Y; Lee, Y; Ma, N; Pannkuk, E; Permaul, E; Rodriquez, O; Zhu, Z | 1 |
Chen, X; Guo, H; Hao, S; He, R; Li, L; Li, Y; Lin, J; Lv, C; Shi, F; Song, X; Tang, H; Ye, G; Yin, Z; Zhao, L; Zou, Y | 1 |
Goodlett, CR; LaCombe, J; Patel, R; Roper, RJ; Stringer, M; Wallace, JM | 1 |
Lai, JY; Luo, LJ; Nguyen, DD | 1 |
Li, H; Lv, L; Yang, F; Yuan, J | 1 |
Du, X; Fu, X; Hou, Y; Huang, Z; Li, J; Luo, Y; Zhuan, Q | 1 |
Liu, HF; Liu, JX; Liu, ZJ; Pan, Q; Su, HY; Yang, C; Zhang, WH | 1 |
Chen, JY; Lu, JH; OuYang, D; Zhang, S; Zhu, Q | 1 |
Li, G; Lin, W; Wang, X; Yang, J; Zheng, X; Zhou, C | 1 |
Balaji, KS; Brindhadevi, K; Melappa, G; Munawer, U; Ningaraju, S; Pugazhendhi, A; Raghavendra, VB | 1 |
Catuara-Solarz, S; De Toma, I; Dierssen, M; Ortega, M; Sabidó, E; Sierra, C | 1 |
An, H; Cai, Z; Cao, J; Chen, N; Li, K; Li, Y; Luo, A; Peng, Y; Tang, Y; Tao, H | 1 |
Ahn, SY; Cho, YK; Choi, C; Jung, YS; Kwon, SW; Lee, YH; Son, Y; Song, HD; Yoon, YC | 1 |
Ceballos, G; Cordero-Anguiano, P; Gonzalez-Ruiz, C; Meaney, E; Mondragón-Lozano, R; Morales-Guadarrama, A; Nájera, N; Salgado-Ceballos, H; Sánchez-Torres, S; Villarreal, F | 1 |
Jiang, X; Li, SJ; Wang, XY; Wang, YQ; Zhuang, G | 1 |
Chen, JH; Hsu, JY; Li, TS; Lin, HH; Tseng, CY; Wong, Y | 1 |
Chen, L; Guo, Y; Li, G; Li, Z; Wan, Z; Zhu, J | 1 |
Guo, H; Hao, S; He, R; Li, L; Li, Y; Shi, F; Song, X; Tang, H; Yan, Q; Ye, G; Zhao, L; Zou, Y | 1 |
Heredia, M; Mollá, B; Sanz, P | 1 |
Almeida-Toledano, L; Andreu-Fernández, V; Aras-López, R; García-Algar, Ó; Gómez-Roig, MD; Martínez, L | 1 |
Hu, YZ; Liu, HX; Shang, P; Tang, SK; Xu, XX; Zheng, G | 1 |
Diao, Y; Hu, X; Li, L; Li, X; Liu, H; Peng, J; Xu, Q; Yin, H; Yu, J; Zhang, C; Zhang, X; Zhang, Y | 1 |
Albaigès, J; De La Torre, R; Dierssen, M; González, A; Gonzàlez, R; Llambrich, S; Martínez-Abadías, N; Sarlé, A; Sevillano, X; Sharpe, J; Starbuck, JM; Vande Velde, G; Wouters, J | 1 |
Abunofal, O; Baig, S; Du, Y; Hicks, J; Mohan, C; Paglicawan, L; Soomro, S; Vanarsa, K | 1 |
Afzal, SM; Ali, N; Islam, J; Rashid, S; Shree, A; Sultana, S; Vafa, A | 1 |
Marchat, LA; Pacheco-Yépez, J; Ramírez-Moreno, E; Rivera, G; Sánchez-Monroy, V; Shibayama-Salas, M; Silva-Olivares, A; Velásquez-Torres, M | 1 |
Ji, A; Li, J; Li, Y; Liu, Z; Wang, Y; Wu, D; Xie, Z; Zhang, Q; Zhong, P | 1 |
Abd El-Fattah, AI; Abu-Elfotuh, K; Ali, AA; Elariny, HA | 1 |
Cheng, L; Luo, ZL; Ren, JD; Sun, HY; Wu, XB | 1 |
Bergamo, P; Bessa-Pereira, C; Dias, R; Freitas, V; Luongo, D; Maurano, F; Mazzarella, G; Pérez-Gregorio, M; Rossi, M; Rotondi Aufiero, V | 1 |
Canela-Tellez, GD; Coral-Vázquez, RM; García, S; Genis-Mendoza, AD; Jiménez-Estrada, I; Martínez-Damas, MG; Nicolini-Sanchez, JH; Pérez-de la Cruz, V; Ramírez-Ramírez, M; Ramos-Chávez, LA | 1 |
Kamal, DAM; Mokhtar, MH; Salamt, N; Zaid, SSM | 1 |
Guo, J; Ji, H; Li, C; Li, S; Lian, S; Liu, Y; Lu, J; Lv, H; Ma, L; Xu, B; Yang, H | 1 |
Guo, Q; Sheng, DY; Xu, ST; Yang, P; Zhang, QZ | 1 |
Ding, F; Tian, X; Xiao, H; Xie, G; Xue, Y; Zhang, M; Zhou, Y | 1 |
Choi, SY; Kim, CE; Lee, H; Shim, W; Yang, J | 1 |
Guo, L; Guo, W; Jin, H; Li, T; Liu, X; Liu, Y; Song, Y; Sun, W; Wang, F; Wu, H; Wu, J; Yang, T; Zhang, H | 1 |
Abeysekera, I; Dria, KJ; Goodlett, CR; LaCombe, J; Roper, RJ; Stancombe, K; Stewart, RJ; Stringer, M; Thomas, J; Wallace, JM | 1 |
Bae, J; Hiroi, S; Huang, Y; Kangawa, K; Kumazoe, M; Nojiri, T; Onda, H; Tachibana, H; Takahashi, T; Takai, M; Takamatsu, K; Takeuchi, C; Tanaka, H; Yamada, S; Yamanouchi, M; Yamashita, S | 1 |
Chen, Y; Guo, Y; Nan, Y; Wang, S; Wang, X; Zhao, Y | 1 |
Fu, M; Fu, S; Hong, T; Liu, Y; Ni, S; Zou, L | 1 |
Airoldi, C; Bonanomi, M; De Gioia, L; Gatta, E; Natalello, A; Pellistri, F; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Vertemara, J; Visentin, C | 1 |
Cheng, J; Jin, XL; Kim, J; Lao, WG; Lin, YG; Ong, M; Qu, XQ; Tan, Y; Xiao, L; Zhu, XQ | 1 |
Cai, Y; Huang, J; Jiang, Z; You, L; Zhang, J | 1 |
Hong, H; Li, Y; Su, B | 1 |
Inagaki, Y; Kato, E; Kawabata, J; Kurokawa, M; Kushibiki, N | 1 |
Benov, L; Khan, KM; Renno, WM | 1 |
Brandl, MB; Cirillo, G; Kavallaris, M; Kimpton, K; Kumar, N; Pasquier, E; Vittorio, O; Yee, EMH | 1 |
Gao, H; Hu, Y; Li, X; Tian, R; Wang, Y; Williams, BR; Xu, P; Yan, F; Ying, L; Zhao, Y | 1 |
Li, Y; Meeran, SM; Tollefsbol, TO | 1 |
Carpes, FP; Garcia, A; Martins, A; Mello-Carpes, PB; Schimidt, HL | 1 |
Chang, SJ; Chang, YC; Chen, YJ; Liu, HW | 1 |
Azarnia, M; Mashayekhi, F; Salehi, Z; Semnani, M | 1 |
Bimonte, S; Cascella, M; Cuomo, A; Mehrabi-Kermani, F; Schiavone, V | 1 |
Almeida, L; Andreu-Fernández, V; Aras-López, R; Martínez, L; Tovar, J | 1 |
Ceballos, G; Meaney, E; Moreno-Ulloa, A; Najera, N; Ortiz, A; Ortiz-Flores, M; Ortiz-Vilchis, P; Pacheco, M; Ramirez-Sanchez, I; Rubio-Gayosso, I; Vega, L; Villarreal, F | 1 |
Ganeshpurkar, A; Saluja, AK | 1 |
Cai, X; Shang, Y; Yang, N; Zhang, H | 1 |
Bhak, G; Lee, JT; Lee, S; Paik, SR; Park, JH; Rhoo, KY; Yang, JE | 1 |
Honda, Y; Ichihara, E; Kiura, K; Kubo, T; Murakami, T; Ninomiya, T; Ochi, N; Takigawa, N; Tanimoto, M; Yamane, H; Yasugi, M | 1 |
Cai, YK; Chen, J; Chen, WJ; Hao, Z; Lv, Y; Wang, HP; Wang, X; Ye, T; Zhao, JY | 1 |
Chen, Y; Cheng, L; Zhang, X; Zhang, Z; Zheng, X | 1 |
Baidoo, JNE; Banerjee, P; Cohen, LS; David, L; Mancuso, A; Mukherjee, S; Sampat, S; Zhou, S | 1 |
Liang, Z; Zhou, T; Zhu, M | 1 |
Liu, B; Wang, M; Wang, X | 1 |
Bing, X; Keyan, C; Linlang, L; Wanwei, D; Xuelei, L | 1 |
Jung, UJ; Kim, SR | 1 |
Govindaraj, S; Muhammed, I; Sankar, S | 1 |
Liu, D | 1 |
Cao, K; Chen, H; Fan, X; Min, X; Tu, S; Xiao, F | 1 |
Chen, D; Wang, W; Zhu, K | 1 |
Albericio, G; Borralleras, C; Bosch-Morató, M; Campuzano, V; Guivernau, B; Muñoz, FJ; Ortiz-Romero, P; Pérez-Jurado, LA | 1 |
Chuang, SM; Ho, WT; Juan, YS; Lee, YC; Lee, YL; Lin, KL; Wu, BN; Wu, WJ | 1 |
Chen, K; Chen, W; Han, Y; Hou, P; Huang, XY; Liu, SL; Qi, J; Wang, Y; Wu, TS; Yao, H; Yu, KF | 1 |
Jimenez-Del-Rio, M; Martinez-Perez, DA; Velez-Pardo, C | 1 |
Cai, M; Jiang, Q; Liu, Q; Wang, X; Wang, Y; Wu, R; Yao, Y | 1 |
He, J; Sun, M; Tian, S | 1 |
Chen, J; Liu, Q; Luo, X; Pan, Z; Ruan, Y; Wang, Q; Yan, YJ; Zhou, L; Zhou, Y | 1 |
Cai, Y; Fu, G; Fu, W; Wang, H; Zhao, H | 1 |
Abdеlaziz, RR; Suddek, GM; Еlmahdy, MK | 1 |
Alexandre, EC; André, DM; Antunes, E; Calixto, MC; Horimoto, CM | 1 |
Chen, F; Hu, L; Huang, Y; Liu, T; Sheng, J; Wang, X; Xiang, Z; Xu, H; Xu, J; Yin, D | 1 |
Fujiki, H; Iida, K; Kobayashi, Y; Namiki, K; Rawangkan, A; Shimizu, Y; Suganuma, M; Wongsirisin, P | 1 |
Chen, Q; Chen, Y; Gu, M; Liu, C; Wan, X; Wang, Z; Yang, T; Zhou, J | 1 |
Canto, P; Coral-Vázquez, RM; De Los Santos, S; Palma-Flores, C; Zentella-Dehesa, A | 1 |
Zhang, G; Zhang, J | 1 |
Guo, L; Li, J; Li, Q; Luo, X; Wu, G; Xi, J; Xue, H | 1 |
Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR | 1 |
Hahm, DH; Lee, B; Lee, H; Shim, I | 1 |
Gan, Y; Liu, J; Liu, L; Tian, J; Zhao, W | 1 |
Ding, L; Gao, X; Hu, J; Yu, S | 1 |
Mao, L; Wang, Y; Xu, P; Zhou, J | 1 |
Gao, D; Li, W; Ma, X; Nie, X; Wang, J; Wang, W; Xing, J; Yu, Z; Zhang, X | 1 |
Cai, H; Chen, S; Dai, J; Dong, F; Huang, YJ; Li, AL; Li, T; Li, WJ; Liu, X; Liu, ZG; Liu, ZS; Pang, X; Wang, M; Wang, X; Wu, SM; Xia, Q; Xia, T; Xing, JQ; Xue, W; Zhang, XM; Zhang, ZY; Zhao, M; Zhou, T | 1 |
Chen, KH; Chen, ZY; Chiu, WY; Huang, HY; Lin, IC; Tseng, CL; Wang, MC; Wu, CC; Yang, WV | 1 |
Ando, Y; Masuda, T; Misumi, Y; Ogura, T; Toyoshima, R; Tsuda, Y; Ueda, M; Yamanaka, K | 1 |
Chen, Z; Jiang, Z; Li, Y; Liu, L; Lu, Z; Qing, H; Yang, Q; Zhang, L; Zhang, X | 1 |
Koyama, N; Maeda, M; Mori, T; Segawa, T; Tan, J; Town, T | 1 |
Fukuhara, K; Iwai, S; Kamei, D; Karasawa, K; Murase, R; Nakano, E; Taki, I | 1 |
Hsiao, HB; Lin, WC; Wu, JB | 1 |
Gulati, A; Gupta, M; Kumari, A; Kumari, M; Padwad, Y; Sharma, A; Sharma, R | 1 |
Casanova, E; Crescenti, A; Gibert-Ramos, A; Salvadó, J | 1 |
Ano, Y; Kita, M; Kondo, K; Ohya, R; Taniguchi, Y | 1 |
Azuma, M; Dat Le, T; Hiraki, N; Inoue, YH; Omura, F; Yamanaka, M; Yoshimoto, Y | 1 |
Eisenstein, M | 1 |
Bai, S; Du, F; Fu, X; Jiao, Y; Ma, J; Wang, L; Zhou, L | 1 |
Chan, SO; Chu, KO; Chu, WK; He, JN; Hui, WK; Li, J; Ng, TK; Pang, CP; Ren, J; Yip, YWY; Yu, QX | 1 |
Bobinski, F; Buffon, LD; da Silva, GS; da Silva, TBGC; David, IMB; de Souza Fernandes, F; Dos Santos Silva Ferreira, JB; Kopper, MBR; Kviecinski, MR; Lüdtke, DD; Martins, DF; Pedrosa, RC; Zeferino, RC | 1 |
Hao, Z; Huang, Z; Ji, L; Jing, X; Sheng, Y; Wang, Z; Zhang, J | 1 |
Huang, MX; Jiang, Y; Lei, GT; Wu, QH; Xing, YW | 1 |
He, L; Liu, G | 1 |
Cui, Z; Jia, L; Qu, Z; Si, P; Sun, C; Wang, W; Xie, T; Xue, Y; Zhen, J | 1 |
Chevalier, C; Créau, N; Dairou, J; Daubigney, F; Delabar, JM; Duchon, A; Gu, Y; Herault, Y; Janel, N; Nalesso, V; Souchet, B; Yu, Y | 1 |
Auladell, C; Barenys, M; Barroso, E; Camins, A; Cano, A; Chang, JH; Espina, M; Ettcheto, M; Folch, J; García, ML; Kühne, BA; Souto, EB; Turowski, P | 1 |
Alves, GM; Assis, ALEM; Athaydes, BR; Campagnaro, BP; Gomes, JVD; Gonçalves, RCR; Kitagawa, RR; Kuster, RM; Nogueira, BV; Pereira, TMC; Rodrigues, RP; Silveira, D | 1 |
Kalantar, H; Khodayar, MJ; Mansouri, E; Pashmforoosh, M; Shariati, S | 1 |
Cortés, MJ; Cuenca-Royo, A; de la Torre, R; de Sola, S; Del Hoyo, L; Dierssen, M; Espadaler, JM; Esteba, S; Farré, M; Gomis-González, M; Hernandez, G; Langohr, K; León, A; Martínez-Leal, R; Milá, M; Novell, R; Ozaita, A; Rodriguez, J; Sánchez-Gutiérrez, J; Xicota, L | 1 |
Shang, YX; Yang, N | 1 |
Almudimeegh, S; Berwick, DC; Cleverley, K; Fisher, EMC; Granno, S; Harvey, K; Heaton, G; Nagda, Z; Nixon-Abell, J; Plagnol, V; Rain, JC; Tosh, J; Tybulewicz, VLJ; Wiseman, FK; Zanda, M | 1 |
An, Y; Chang, Y; Cheng, J; Dang, H; Feng, J; Guo, H; Luo, K; Ma, C; Qiao, L; Shao, H; Tian, J; Xie, L; Xing, W; Yang, J; Yuan, Y | 1 |
Cho, YY; Kang, HC; Lee, HE; Lee, HS; Lee, JY; Park, YB; Yang, G | 1 |
Canto, P; Coral-Vázquez, RM; De Los Santos, S; Leal-García, M; Méndez, JP; Reyes-Castro, LA; Zambrano, E | 1 |
Fan, SM; Wang, J; Zhang, J | 1 |
Baig, S; Ding, H; Du, Y; Hicks, J; Mohan, C; Soomro, S; Vanarsa, K | 1 |
Ashafaq, M; Ejaz Ahmed, M; Islam, F; Javed, H; Khan, A; Khan, MM; Safhi, MM; Tabassum, R; Vaibhav, K | 1 |
Andrade, JP; Assunção, M; Cardoso, A; Carvalho, F; Lukoyanov, N; Rodrigues, J | 1 |
Bishayee, A; Darvesh, AS | 1 |
Czernizer, E; Dardik, A; Dardik, H; Hoffmann, T; London, D; Naftalovich, R; Orozco-Sevilla, V; Yang, C | 1 |
Asanoma, M; Hanaoka, J; Ikemoto, T; Imura, S; Komatsu, M; Mori, H; Morine, Y; Saito, Y; Shimada, M; Takasu, C; Utsunomiya, T; Yamada, S | 1 |
Cai, Y; Hashizume, T; Kurita-Ochiai, T; Yamamoto, M | 1 |
He, M; Liu, MY; Tang, QS; Wang, S; Wei, MJ; Yao, WF; Zhao, HS | 1 |
Baba, M; Ishii, K; Muroi, K; Osada, K; Uematsu, H; Yui, K | 1 |
Cao, YP; Han, K; Jia, N; Kong, JJ; Ren, GR; Sha, S; Zhang, XM | 1 |
Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B | 1 |
Diao, Y; Ge, R; Tao, L; Xiong, XC; Yuan, W; Zhu, Y | 1 |
Kim, DS; Kim, HK; Lee, JJ; Myung, CS; Sung, YY; Yang, WK | 1 |
Benejam, B; Bizot, JC; Blehaut, H; Catuara, S; Covas, MI; Cuenca, A; De la Torre, R; de Lagran, MM; De Sola, S; Delabar, JM; Dierssen, M; Duchon, A; Farré, M; Fitó, M; Herault, Y; Janel, N; Langohr, K; Pons, M; Pujadas, M; Rodriguez, J | 1 |
Jang, JY; Jeon, YK; Kim, CW; Lee, JK | 1 |
Hollingsworth, A; Khurana, S; Piche, M; Tai, TC; Venkataraman, K | 1 |
Chen, F; Lin, Y; Liu, G; Yao, C; Zhang, J | 1 |
Jankun, J; Keck, RW; Selman, SH | 1 |
Bisch, F; Derossi, S; Dickinson, D; Hahn, E; Hsu, S; Ma, YH; Ohno, S; Thomas, C; Yamamoto, T; Yates, N; Yu, H | 1 |
Guo, Y; Jiang, L; Liu, D; Zhang, X; Zheng, C | 1 |
Date, F; Mori, S; Ono, M; Saito, K | 1 |
Goda, T; Mochizuki, K; Suzuki, T; Uchiyama, Y | 1 |
Ceballos, G; Chamorro-Cevallos, G; Garduño-Siciliano, L; Gutiérrez-Salmeán, G; Meaney, E; Ortiz-Vilchis, P; Ramírez-Sánchez, I; Vacaseydel, CM; Villafaña, S; Villarreal, F | 1 |
Amankwah, E; Choi, J; Chornokur, G; Connors, S; Cornnell, H; Engelman, RW; Hashim, AI; Kim, SJ; Kumar, N; Park, HY; Park, JY; Rincon, M; Tsai, YY | 1 |
Bianchi, DW; Delabar, JM; Guedj, F | 1 |
Krishnan, TR; Mangaiah, S; Murugaiyan, U; Periandavan, K; Srinivasan, A; Vadivel, SK; Velusamy, P | 1 |
Chung, SK; Koh, CH; Lee, HS | 1 |
Liu, CX; Min, LQ; Song, CG; Yang, X; Zhao, CS | 1 |
Jyoti, S; Naz, F; Siddique, YH | 1 |
Bettaieb, A; Fraga, CG; Haj, FG; Miatello, RM; Oteiza, PI; Rodriguez Lanzi, C; Vazquez Prieto, MA | 1 |
Feng, Z; Liu, J; Long, J; Tang, Y | 1 |
Actis-Goretta, L; Demont, A; Holvoet, S; Lepage, M; Lévêques, A; Mercenier, A; Nutten, S; Singh, A | 1 |
Kurita-Ochiai, T; Yamamoto, M | 1 |
Al-Maghrebi, M; Khraishah, H; Rao, MS; Renno, WM | 1 |
Pan, J; Xu, X; Zhou, X | 1 |
Bonanomi, M; Colombo, G; Cornelli, G; Doglia, SM; Malabarba, MG; Natalello, A; Pastori, V; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Visentin, C | 1 |
Chan, KP; Chan, SO; Chu, KO; Li, WY; Pang, CP; Qin, YJ; Ren, JL; Yang, YP; Yip, YW | 1 |
Li, Q; Lin, F; Wang, S; Xu, A; Zhu, Y | 1 |
Acquas, E; Arote, S; Cotti, E; Gaikar, M; Kasture, SB; Kasture, V; Rosas, M; Salve, B | 1 |
Cho, EJ; Choi, YY; Fujii, H; Kim, HY; Maeda, T; Shibamoto, T; Yokozawa, T | 1 |
Chen, B; Hu, Z; Jiang, B; Liu, G; Pei, F; Song, J; Yang, X; Zou, P | 1 |
Huang, CY; Li, GT; Pan, JH | 1 |
Ajit, D; Klakotskaia, D; Schachtman, TR; Serfozo, P; Simonyi, A; Sun, GY; Walker, JM; Weisman, GA; Wood, WG | 1 |
Calabró, V; Fraga, CG; Galleano, M; Piotrkowski, B | 1 |
Brown, WT; Meeker, HC; Ramakrishna, N | 1 |
Tagami, M; Yamagata, K; Yamori, Y | 1 |
Aswar, UM; Kandhare, AD; Mohan, V; Thakurdesai, PA | 1 |
Choudhury, M; Cobelli, NJ; Goldring, MB; Hanstein, R; Hardin, JA; Hirsh, DM; Kim, SJ; Leong, DJ; Majeska, RJ; Schaffler, MB; Spray, DC; Sun, HB | 1 |
Dähnert, I; Dhein, S; Einenkel, A; Grassl, M; Kiefer, P; Kühne, L; Salameh, A; Vollroth, M; von Salisch, S | 1 |
Bian, X; Du, F; Liu, N; Su, X; Sun, G; Wang, B; Wang, Y; Zhou, G | 1 |
Chang, KC; Lin, RF; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH | 1 |
Chen, B; Hao, Q; Hu, Z; Jiang, B; Li, X; Liu, G; Yang, X; Zou, P | 1 |
Al-Abbad, J; Al-Ali, W; Ali, H; Asfar, S; Dashti, A; Dashti, H; Jamal, MH; Mathew, C | 1 |
Franczyk-Żarów, M; Kostogrys, RB; Maślak, E; Mika, M; Wikiera, A | 1 |
Arumuggam, N; Bhowmick, NA; Rupasinghe, HP | 1 |
Chen, J; Chen, T; Du, L; Li, J; Liu, P; Peng, S; Song, H; Wang, M; Xu, J | 1 |
Date, F; Hong, G; Mori, S; Saito, K | 1 |
Lu, M; Wu, LQ | 1 |
Abe, S; Ezawa, K; Hayama, K; Kishi, A; Matsukawa, T; Sato, N; Suzuki, M; Takahashi, M; Yamazaki, M | 1 |
Chang, X; Chen, Y; Cheng, S; Dun, W; Fang, S; Gu, X; He, W; Hou, X; Hu, Q; Liu, S; Mo, Y; Rong, C; Su, R; Wang, Q; Yang, C; Zhang, C; Zhang, L | 1 |
Deng, YP; Gan, L; Guo, JQ; Li, H; Lu, XC; Luo, BD; Meng, ZJ; Xiong, RB; Zheng, ZW; Zou, F | 1 |
Feng, X; Shen, K; Su, R; Xie, H; Zheng, S; Zhou, L | 1 |
Chen, Y; Deng, Y; Ding, Y; Qian, K; Sun, X | 1 |
Chen, GD; Feng, XL; Gao, H; Guo, LD; He, RR; Huang, Y; Li, XX; Yao, XS; Yu, Y; Zhao, Q; Zheng, YZ; Zhou, WX | 1 |
Akdag, R; Alagoz, F; Belen, AD; Cetinalp, NE; Dalgic, A; Divanlioglu, D; Guvenc, Y; Helvacioglu, F; Koksal, I; Take, G; Yildirim, AE | 1 |
Chen, ZS; He, F; Yang, J; Zhang, X | 1 |
Feng, ZP; Guo, J; Kang, YM; Li, HB; Liu, JJ; Qi, J; Shi, T; Shi, XL; Su, Q; Wang, ML; Yi, QY; Yu, XJ; Zhang, DM; Zhang, Y; Zhu, GQ | 1 |
Abeysekera, I; Blazek, JD; Li, J; Roper, RJ | 1 |
Ding, H; Li, J; Li, X; Li, Z; Niu, Y; Wu, S; Xiang, J; Yue, Y | 1 |
Cheng, YT; Ho, CY; Jhang, JJ; Lu, CC; Yen, GC | 1 |
Tang, CB; Wang, S; Zhou, Y | 1 |
D'Angelo, J; Li, J; Li, W; Wang, H; Wu, AH; Wu, R; Zhu, S | 1 |
Gómez, C; Gorostieta-Salas, E; Guevara, J; Montes, S; Pérez-Severiano, F; Ríos, C; Rubio, C; Rubio-Osornio, M | 1 |
de la Torre, R; Dierssen, M; Rodriguez-Morato, J; Xicota, L | 1 |
Burton, DR; Douglas, D; Egli, A; Forester, S; Houghton, M; Humar, A; Kneteman, N; Lambert, J; Law, J; Law, M; Lund, G; O'Shea, D; Tyrrell, DL | 1 |
Bongen, P; Brener, O; Demuth, HU; Dunkelmann, T; Funke, SA; Gremer, L; Hoyer, W; Janssen, A; Jürgens, D; Kadish, I; Kutzsche, J; Langen, KJ; Mirecka, EA; Nagel-Steger, L; Oesterhelt, F; Pietruszka, J; Rudolph, S; Tusche, M; van Groen, T; Willbold, D; Willuweit, A | 1 |
Chung, WY; Ko, TH; Li, TS; Lin, JH; Lin, YH; Wang, SH; Yao, CH | 1 |
Ahmed, S; Chourasia, M; Riegsecker, S; Singh, AK; Umar, S | 1 |
Hou, YC; Lee Chao, PD; Lin, SP; Peng, YH; Sweet, DH; Yu, CP | 1 |
Bhagat, RM; Rawat, AK; Singh, BN; Singh, BR | 1 |
Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L | 1 |
Funamoto, M; Hyon, SH; Ikeda, T; Masumoto, H; Minakata, K; Sakata, R; Setozaki, S; Takaori, K; Taki, T; Yamazaki, K | 1 |
Abeysekera, I; Berman, AG; Dria, KJ; Georgiadis, TM; Hammond, MA; Roper, RJ; Thomas, J; Wallace, JM | 1 |
Ahmad, N; El-Abd, S; Mukhtar, H; Siddiqui, IA; Singh, CK | 1 |
Janakiram, NB; Kumar, G; Madka, V; Mohammed, A; Rao, CV | 1 |
You, YP | 1 |
Aksakal, İA; Demir, A; Engin, MS; Keleş, MK; Küçüker, İ; Önger, ME | 1 |
Sanna, V; Siddiqui, IA | 1 |
Chang, KC; Chen, CN; Lin, RF; Shih, RL; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH | 1 |
Cho, ML; Jung, YO; Kim, EK; Kim, HY; Kwon, JE; Lee, SH; Lee, SY; Oh, HJ; Park, MK; Park, SH; Ryu, JG; Son, HJ | 1 |
Contestabile, A; de Bari, L; de Rasmo, D; Henrion-Caude, A; Signorile, A; Vacca, RA; Valenti, D | 1 |
Aguilera Olvera, R; Joe, B; Kennett, MJ; Lambert, JD; Singh, V; Vijay-Kumar, M; Xiao, X; Yeoh, BS | 1 |
Ceballos, G; Moreno-Ulloa, A; Ramírez-Sánchez, I; Rodríguez, A; Villarreal, F | 1 |
Bona, G; Buonpensiero, P; De Gregorio, F; De Rosa, G; De Stefano, D; Di Pasqua, A; Esposito, S; Ferrari, E; Grassia, R; Guido, S; Kroemer, G; Leone, CA; Lusa, S; Maiuri, L; Maiuri, MC; Mehta, A; Raia, V; Salvadori, L; Sana, I; Sepe, A; Stoll, G; Tosco, A | 1 |
Bayliss, R; Brown, K; Gescher, A; Howells, L; Karmokar, A; Khan, S; Thomas, AL | 1 |
Cho, WJ; Han, JY; Jung, YD; Kim, JH; Kim, JK; Lee, SG; Oh, BS | 1 |
Bitzer, ZT; Elias, RJ; Lambert, JD; Vijay-Kumar, M | 1 |
Jian, J; Xuan, F | 1 |
Ishizaki, Y; Kikuzaki, H; Kobayashi, K; Kojo, S | 1 |
Heidor, R; Moreno, FS; Pogribny, IP | 1 |
Carollo, CA; Castro, AH; de Carvalho Veloso, C; de Matos, NA; de Siqueira, JM; De Vos, RC; do Carmo, LF; do Nascimento, SB; do Nascimento, TV; Klein, A; Saldanha, AA; Soares, AC; Toffoli-Kadri, MC | 1 |
Chen, KH; Chen, ZY; Fang, HW; Hung, YJ; Tseng, CL | 1 |
Chen, J; Song, H | 1 |
Botelho, PB; de Morais, AC; Ferreira, MA; Mota, JF; Silva, DM | 1 |
Bai, L; Chen, J; Jin, L; Li, M; Liang, Z; Lu, C; Lu, L; Tang, H; Tang, L; Wang, K; Wu, R; Yan, Y; Ye, Y | 1 |
Bartesaghi, R; Ciani, E; Emili, M; Giacomini, A; Guidi, S; Rimondini, R; Sassi, M; Stagni, F; Trazzi, S | 1 |
Gelling, RW; Han, W; Kek, HC; Li, H; Lim, J | 1 |
Hirao, S; Ikeda, T; Kuwahara, K; Masumoto, H; Minakata, K; Sakata, R; Setozaki, S; Yamazaki, K | 1 |
Ashida, H; Ito, C; Nanba, F; Toda, T; Wang, L; Yamashita, Y | 1 |
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Abadie, J; Beck, L; Gauthier, O; Guicheux, J; Hivernaud, V; Houard, X; Krisa, S; Lesoeur, J; Masson, M; Merceron, C; Mével, E; Nourissat, G; Richard, T; Urban, N; Vinatier, C; Wittrant, Y | 1 |
Guo, LL; Jin, HM; Pan, Y; Yang, XH; Zhan, XL; Zhang, BL | 1 |
Cai, YW; Cheng, M; Gao, HQ; Li, BY; Li, XL; Pei, F; Wang, QZ; Wang, YJ; Zhang, J; Zhang, Z; Zhou, Y | 1 |
Kochi, T; Sakai, H; Seishima, M; Shimizu, M; Shirakami, Y | 1 |
Hwang, S; Jun, DY; Kim, SH; Lee, J; Lee, SG; Park, GC; Song, GW; Tak, E | 1 |
Cobelli, NJ; Hardin, JA; He, Z; Hirsh, DM; Kim, SJ; Leong, DJ; Liu, L; Sun, HB; Wang, A; Xu, L | 1 |
Bai, Q; Dong, T; Lou, J; Lyu, Z; Pan, Z; Yang, X | 1 |
Asano, T; Iwashita, M; Kanematsu, T; Kushiyama, A; Nagayasu, S; Nishimura, F; Sano, T; Sanui, T; Shinjo, T; Suzuki, S; Yamashita, A | 1 |
McGeary, A; Penack, O; Rudloff, S; Westphal, S; Wilke, A | 1 |
Chang, CY; Chen, KH; Chen, ZY; Lin, FH; Liu, GS; Miyagawa, T; Tseng, CL; Wang, MC | 1 |
Adhami, VM; Chamcheu, JC; Jashari, R; Mukhtar, H; Rady, I; Sanna, V; Sechi, M; Siddiqui, IA; Singh, CK | 1 |
Blazek, JD; Ghoneima, A; Harrington, E; Kula, K; McElyea, SD; Roper, RJ; Starbuck, JM; Tumbleson-Brink, DM | 1 |
Fumoto, T; Imaizumi, T; Masumoto, S; Matsuda, N; Miura, T; Naraoka, M; Ohkuma, H; Shoji, T; Wang, L | 1 |
Altavilla, D; Bitto, A; Canalini, F; Giuliani, D; Guarini, S; Irrera, N; Minutoli, L; Ottani, A; Pallio, G; Rinaldi, M; Squadrito, F; Vandini, E; Zaffe, D | 1 |
Baek, SJ; Eling, TE; Hara, Y; Lee, SH; McEntee, MF; Sukhthankar, M; Yamaguchi, K | 1 |
Barraza-Hidalgo, M; Ceballos, G; Cortez-Gomez, B; Cruz, M; Rivas, M; Romero-Perez, D; Villarreal, F; Yamazaki, KG | 1 |
Biao, W; Horiuchi, M; Jun, L; Kumagai, S; Kurosaka, M; Morinobu, A; Sakai, Y; Tanaka, S; Tsuji, G | 1 |
Ahmed, S; Campbell, PL; Koch, AE; Kwan, K; Marotte, H; Pakozdi, A; Rabquer, BJ; Ruth, JH | 1 |
Bisch, F; Camba, AM; Chu, TC; Dickinson, DP; Gillespie, K; Hsu, SD; Kodani, I; Looney, S; Ogbureke, KU; Qin, H; Schuster, GS; Sharawy, M; Wu, M | 1 |
Hail, N; Lotan, R | 1 |
Chen, R; Ruan, H; Wang, X; Yang, Y; Zhu, X | 1 |
Akdemir, F; Kucuk, O; Onderci, M; Ozercan, IH; Sahin, K; Sahin, N; Seren, S | 1 |
Chu, CY; Lui, WT; Ng, PS; Rogers, MS; Wang, CC; Xu, H | 1 |
Gu, ZL; Guo, CY; Sheng, R; Xie, ML; Zhou, WX | 1 |
Auclair, S; Besson, C; Chauvet, S; Gueux, E; Mazur, A; Milenkovic, D; Morand, C; Scalbert, A | 1 |
Chen, MH; Hong, CY; Hou, KL; Kok, SH; Lee, YL; Lin, SK; Lin, YT; Wang, CC | 1 |
Chen, DD; Dong, YG; He, JG; Liu, D | 1 |
Bao, L; Guo, X; Kurihara, H; Liu, H; Xu, J; Yao, X | 1 |
Elgin, G; Ince, I; Karabay-Yavasoglu, NU; Yesil-Celiktas, O | 1 |
Kumar, A; Kumar, P | 2 |
Isobe, M; Morishita, R; Nagai, R; Suzuki, J | 1 |
Chopra, K; Kuhad, A; Sachdeva, AK; Tiwari, V | 1 |
Naito, Y; Yoshikawa, T | 1 |
Au, AY; Frondoza, CG; Grzanna, MW; Heinecke, LF; Mochal, CA; Rashmir-Raven, A | 1 |
Chien, CT; Li, PC; Lin, CY; Liou, SY; Yang, CH; Yang, JH | 1 |
Geraldine, P; Ramesh, E; Thomas, PA | 1 |
Abdelsaid, MA; Al-Shabrawey, M; El-Remessy, AB; Matragoon, S; Pillai, BA; Prakash, R | 1 |
Bae, HB; Jeong, CW; Kim, HS; Kim, JP; Kim, SJ; Kim, WM; Kwak, SH; Lee, HG; Li, M | 1 |
Hua, H; Jiang, Y; Jing, J; Li, M; Luo, T; Sun, X; Wang, J; Yin, Y; Zhang, Y | 1 |
Arora, V; Chopra, K; Kuhad, A; Sachdeva, AK; Tiwari, V | 1 |
Asagiri, K; Asakawa, T; Kage, M; Kobayashi, H; Tanaka, Y; Tanikawa, K; Yagi, M | 1 |
Croft, KD; Hime, N; Hodgson, JM; Loke, WM; Magat, M; McKinley, AJ; Proudfoot, JM; Stocker, R | 1 |
Amit, T; Kalfon, L; Mandel, SA; Reznichenko, L; Youdim, MB | 1 |
Arab, L; Liebeskind, DS | 1 |
Bolduc, V; Drouin, A; Gendron, ME; Mamarbachi, AM; Merhi, Y; Nguyen, A; Théorêt, JF; Thorin, E; Thorin-Trescases, N | 1 |
Chung, ME; Hong, BY; Im, S; Kim, HS; Kim, HW; Kim, TM; Kim, YK; Ko, YJ; Lee, JI; Lim, SH | 1 |
Delabar, JM | 1 |
Li, H; Yang, P | 1 |
Chen, F; Jiang, L; Jin, Y; Xie, J; Yang, D; Zhang, T | 1 |
Loarca-Piña, G; Mendoza, S; Ramos-Gómez, M; Reynoso, R | 1 |
Jeon, BS; Kim, JM; Kim, JS; O, JJ | 1 |
Barraza-Hidalgo, M; Ceballos, G; Rivas, MM; Taub, PR; Villarreal, FJ; Yamazaki, KG; Zambon, AC | 1 |
Hong, JT; Lee, MK; Lee, YM; Oh, JH; Oh, KW; Park, KS; Yoo, HS | 1 |
Cho, YH; Ha, US; Han, CH; Kim, HW; Lee, CB; Lee, SJ; Sohn, DW; Yoon, BI | 1 |
Chopra, K; Kuhad, A; Tiwari, V | 1 |
Guo, D; Guo, S; Hu, Y; Liao, H; Liu, P; Wang, D; Wang, Y | 1 |
Bray, TM; Bruno, RS; Dashwood, RH; Ho, E; Hsu, A; Löhr, CV; Taylor, AW | 1 |
Fernandez, JW; Obregon, D; Rezai-Zadeh, K; Tan, J | 1 |
Azuma, T; Ekuni, D; Endo, Y; Irie, K; Maruyama, T; Morita, M; Tamaki, N; Tomofuji, T; Yamamoto, T | 1 |
Altavilla, D; Bitto, A; Fazzari, C; Irrera, N; Minutoli, L; Polito, F; Squadrito, F | 1 |
Du, CK; Lu, QW; Miwa, Y; Morimoto, S; Nagata, K; Ohta, M; Ohtsuki, I; Sasaguri, T; Tadano, N; Takahashi-Yanaga, F; Tanokura, M; Xie, MF; Yumoto, F; Zhan, DY | 1 |
Bian, JS; Bin Sattar, MM; Huang, Y; Lee, HC; Zheng, J | 1 |
Almeida, FR; Ayres, MC; Cavalheiro, AJ; Chaves, MH; Lopes, LS; Marques, RB; Pereira, SS; Vieira Júnior, GM | 1 |
Arora, SK; Bharrhan, S; Chopra, K; Rishi, P; Toor, JS | 1 |
Chen, TC; Golden, EB; Hofman, FM; Louie, SG; Schönthal, AH; Sivakumar, W; Thomas, S; Wang, W | 1 |
Kannaiyan, R; Sethi, G; Shanmugam, MK | 1 |
Alcorn, JF; Craigo, JK; Kolls, JK; Qin, S; Reinhart, TA; Tarwater, PM; Tjoeng, C | 1 |
Chen, X; Gao, H; Guo, TZ; Hou, YL; Kobayashi, H; Sun, SC; Tang, JS; Yao, XS; Ye, WC | 1 |
Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK | 1 |
Jin, XF; Liu, Q; Ran, ZH; Tong, JL; Xiao, SD; Xu, Q; Xu, XT; Yang, CH | 1 |
Bharrhan, S; Chopra, K; Koul, A; Rishi, P | 1 |
Keck, RW; Selman, SH | 1 |
Amengual-Cladera, E; Gómez-Pérez, Y; Gomila, I; Lladó, I; Nadal-Casellas, A; Prieto, RM; Proenza, AM | 1 |
Haramizu, S; Hase, T; Murase, T; Ota, N | 1 |
Chen, YK; Cheung, C; Lee, MJ; Liu, AB; Lu, YP; Reuhl, KR; Yang, CS | 1 |
Arcari, M; Astancolle, S; Azzali, G; Bettuzzi, S; Caldara, GF; Corti, A; Davalli, P; Davoli, S; Rizzi, F; Silva, A; Vitale, M | 1 |
Kang, H; Kim, HO; Kim, HS; Kim, MH; Kim, YY; Park, YM; Up No, S | 1 |
Chauhan, SK; Dana, R; Lee, HS; Nallasamy, N; Okanobo, A | 1 |
Chen, CH; Chuang, SM; Huang, CH; Juan, YS; Levin, RM; Liu, KM; Long, CY | 1 |
Ho, HY; Ko, YJ; Lin, WC; Wu, JB | 1 |
Campbell, PM; Deng, Y; Liao, DJ; Matter, B; Mishra, SK; Nanda, S; Saleem, M; Schuster, T; Siddique, HR; Villalta, P; Wang, L | 1 |
Aburada, M; Kamiya, T; Kamiya-Sameshima, M; Miyamoto, K; Nagamine, R; Sai, Y; Shimada, T; Takagaki, K; Tokuhara, D; Tsubata, M | 1 |
Choi, JI; Kim, WM; Kim, YO; Lee, HG; Yoon, MH | 1 |
Almeida, MR; Ferreira, N; Saraiva, MJ | 1 |
Baraghis, E; Bolduc, V; Duquette, N; Lambert, J; Lesage, F; Thorin, E; Thorin-Trescases, N | 1 |
Dorchies, OM; Nakae, Y; Ritter, C; Ruegg, UT; Stoward, PJ; Zimmermann, BF | 1 |
Altavilla, D; Bitto, A; David, A; Irrera, N; Minutoli, L; Rinaldi, M; Squadrito, F; Venuti, FS | 1 |
Aini, H; Asou, Y; Iwata, M; Koga, D; Ochi, H; Okawa, A; Okazaki, M; Sano, A | 1 |
Anandhan, A; Janakiraman, U; Manivasagam, T | 1 |
Chang, WC; Chuang, SM; Huang, CH; Juan, YS; Lee, YL; Levin, RM; Liu, KM; Long, CY; Wu, TH | 1 |
Boreddy, PR; Chennasamudram, SP; Kudugunti, S; Moridani, MY; Vasylyeva, TL | 1 |
Anandhan, A; Essa, MM; Manivasagam, T | 1 |
Islam, MA | 1 |
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z | 1 |
Chiba, M; Kawano, S; Nakagami, T; Sanada, Y; Sugiyama, A; Tajiri, T; Toki, A | 1 |
Awwad, J; Bazi, T; Hajj-Hussein, IA; Hijaz, M; Jurjus, A; Shams, A | 1 |
Chu, TC; Derossi, S; Dickinson, D; Hsu, S; Ogbureke, K; Ohno, S; Yamamoto, T; Yu, H | 1 |
Chen, K; Chen, L; Jia, Q; Li, Y; Sun, P; Wang, H; Wang, T | 1 |
Johnson, RJ; Lanaspa, MA; Maeshima, Y; Miyazaki, M; Nakagawa, T; Sato, W; Schreiner, GF; Suzuki, N; Tamura, Y; Tanabe, K; Villarreal, FJ | 1 |
Choi, DY; Han, SB; Hong, JT; Lee, YJ; Oh, KW; Yun, YP | 1 |
He, M; Huang, Q; Huang, R; Liao, M; Lin, X; Wei, L; Zhang, S; Zheng, L; Zhuo, L | 1 |
Barañao, RI; Bastón, JI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG; Singla, JJ | 1 |
da Silva, EL; Hort, MA; Maraschin, M; Minatti, J; Ribeiro-do-Valle, RM; Wazlawik, E; Zaleski, FL | 1 |
Cai, Y; Chen, TT; Gao, S; Geng, B; Liu, PQ; Ye, JT; Yu, SS; Yu, Y | 1 |
Hashimoto, S; Imano, M; Ito, A; Itoh, T; Matsuo, K; Mizuguchi, N; Munakata, H; Nakayama, T; Nishida, S; Satou, T; Tabuchi, M; Tsubaki, M | 1 |
Fukui, M; Kang, KS; Wen, Y; Yamabe, N; Zhu, BT | 1 |
Stanely Mainzen Prince, P | 1 |
Anderson, J; Cantilena, S; Chayka, O; D'Alicarnasso, M; Himoudi, N; Morgenstern, DA; Pearson, K; Piotrowska, I; Sala, A; Santilli, G; Thrasher, AJ | 1 |
Sui, FX; Teng, X; Wu, YB; Yu, JF; Zhao, CG; Zhou, P | 1 |
Gupta, S; Mukhtar, H | 1 |
Arteel, GE; Froh, M; Gäbele, E; Konno, A; McKim, SE; Sies, H; Thurman, RG; Uesugi, T | 1 |
Akagi, K; Futakuchi, M; Hirose, M; Mizoguchi, Y; Shirai, T; Yamaguchi, T | 1 |
Imamura, M; Itami, A; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Maeda, M; Sato, F; Shimada, Y | 1 |
Matsushima, M; Sato, D | 1 |
Jung, JG; Kim, CY; Lee, JJ; Lee, SR; Lee, SY | 1 |
Beissenhirtz, M; Büttemeyer, R; Lisdat, F; Mall, JW; Philipp, AW; Schlenzka, L | 1 |
Cho, EJ; Rhyu, DY; Yokozawa, T | 1 |
Cheng, CH; Kong, LD; Wang, Y; Yang, C; Zhang, X; Zhu, JX | 1 |
Appleton, I; Hall, I; Howard, R; Kapoor, M | 1 |
Ardévol, A; Arola, L; Bladé, MC; Blay, M; Pinent, M; Salvadó, MJ | 1 |
Amit, T; Mandel, S; Weinreb, O; Youdim, MB | 1 |
Astancolle, S; Bettuzzi, S; Brausi, M; Caporali, A; Corti, A; D'Arca, D; Davalli, P | 1 |
Albini, A; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M; Pezzato, E; Sartor, L | 1 |
Crespy, V; Williamson, G | 1 |
Mandel, S; Maor, G; Youdim, MB | 1 |
Campbell, C; Chavin, KD; Cheng, G; Donovan, JL; Evans, Z; Fiorini, RN; Haines, JK; Markowitz, JS; May, HD; Milliken, CE; Rodwell, D; Schmidt, MG | 1 |
Auger, C; Besançon, P; Bornet, A; Caporiccio, B; Cristol, JP; Gérain, P; Lequeux, N; Rouanet, JM; Serisier, S; Teissedre, PL | 1 |
Chopra, K; Kaur, S; Singal, A; Tirkey, N | 1 |
Abel, S; Burns, SA; Clifford, AJ; Dingley, KH; Ebeler, SE; Mitchell, AE; Steinberg, FM; Ubick, E | 1 |
Cho, YH; Han, CH; Kang, SH; Kim, SW; Lee, SJ; Lee, YS; Shin, OR; Sim, YC | 1 |
Banerjee, S; Das, S; Ganguly, C; Manna, S; Panda, CK; Saha, P | 1 |
Astancolle, S; Belloni, L; Bettuzzi, S; Caporali, A; Corti, A; Davalli, P; Remondini, D; Rizzi, F; Scaltriti, M | 1 |
Hwang, MS; Kim, HT; Kim, HY; Kim, J; Kim, MH; Kim, OH; Kim, SH; Koh, SH; Lee, KW; Lee, KY; Lee, SM; Lee, YJ; Song, C; Yang, KW | 1 |
Buetler, TM; Dorchies, OM; Kucera, P; Ruegg, UT; Vuadens, O; Wagner, S; Waldhauser, K | 1 |
Clark, J; You, M | 1 |
Chang, KW; Hsu, HC; Ko, SY; Lin, SC; Liu, TY | 1 |
Choi, IW; Kim, SH; Lee, CM; Lee, HK; Moon, DO; Park, HJ; Park, YM; Roh, HJ | 1 |
Bani, D; Ciampa, A; Giannini, L; Masini, E; Menegazzi, M; Nistri, S; Suzuki, H; Suzuki, Y | 1 |
Catapano, AL; Marchesi, P; Norata, GD; Passamonti, S; Pirillo, A; Violi, F | 1 |
Guiramand, J; Lanté, F; Maurice, T; Nedjar, M; Récasens, M; Thethi, K; Vignes, M | 1 |
Bal dit Sollier, C; Berge, N; Brézillon, C; Callebert, J; Drouet, L; Philippe, C; Rabot, S; Soulat, T; Teissedre, PL | 1 |
Choi, MS; Jang, YH; Kim, AR; Kim, JM; Lee, MY; Lee, SR; Lee, YC; Mun, KC; Park, HR; Park, NH; Shin, HY | 1 |
Chen, S; Le, W; Li, L; Li, X; Luo, G; Xu, Z | 1 |
Agbor, GA; Bose, P; Muchler, S; Proch, J; Samman, N; Shuta, D; Taffera, P; Vinson, JA | 1 |
Chiba, T; Fukuzawa, Y; Hirai, M; Hotta, Y; Ishikawa, N; Isobe, F; Kawamura, N; Nakano, A; Wakida, Y | 1 |
Aktas, O; Waiczies, S; Zipp, F | 1 |
Bollag, WB; Borke, J; Camba, AM; Dickinson, DP; Hsu, SD; Ogbureke, KU; Qin, H; Schuster, GS; Sharawy, MM; Stöppler, HJ; Winger, JN | 1 |
Gaedicke, G; Huebener, N; Lode, HN; Strandsby, A | 1 |
Hirose, M; Ishii, Y; Kanki, K; Kuroiwa, Y; Mitsumori, K; Nakazawa, H; Nishikawa, A; Umemura, T | 1 |
Cao, LQ; Chen, XL; Huang, XH; Li, W; Liu, YJ; Sun, K; Wang, Q; Zhang, LJ; Zhen, MC | 1 |
Catravas, JD; Denenberg, AG; Hake, PW; Lahni, PM; Snead, C; Wheeler, DS; Wong, HR; Zingarelli, B | 1 |
Aruoma, OI; Fujii, H; Nishioka, H; Sun, B; Tomobe, K | 1 |
Egashira, N; Egawa, T; Fujiwara, M; Irie, K; Iwasaki, K; Kitamura, Y; Mishima, K; Motohashi, K; Orito, K; Pu, F; Tanaka, Y | 1 |
Camino, A; Esteva, MI; Flawiá, MM; Güida, MC; Paveto, C; Torres, HN | 1 |
Bahcecioglu, IH; Dagli, AF; Kuzu, N; Ozercan, IH; Sahin, K; Ustündag, B | 1 |
Ju, J; Lambert, JD; Lu, G; Yang, CS | 1 |
Rao, ChV; Vijayakumar, M | 1 |
Abboud, PA; Burroughs, TJ; Hake, PW; Mangeshkar, P; O'Connor, M; Odoms, K; Wong, HR; Zingarelli, B | 1 |
Chen, Y; Lin, YZ; Song, YG | 1 |
Burckhardt, IC; Cheng, Y; Dayyat, E; Goldbart, AD; Gozal, D; Li, RC; Row, BW | 1 |
Devika, PT; Prince, PS | 1 |
Joghataie, MT; Nobakht, M; Rasoolijazi, H; Roghani, M | 1 |
Arendash, GW; Fernandez, F; Hou, H; Jensen, M; Rezai-Zadeh, K; Runfeldt, M; Shytle, RD; Tan, J | 1 |
Siegers, CP | 1 |
Akagi, K; Hara, Y; Hirose, M; Hoshiya, T; Ito, N; Takahashi, S | 1 |
Güran, Z; Kozluca, O; Kulaksiz, T; Olcay, E; Sürücü, S; Uskent, N | 1 |
German, JB; Irving, D; Rein, D; Walzem, RL; Xu, R; Yokoyama, WH | 1 |
Isogai, E; Isogai, H; Nishikawa, T; Takeshi, K | 1 |
de Villiers, WJ; McClain, CJ; Varilek, GW; Yang, F | 1 |
Sato, D | 1 |
Chung, JY; Lee, MJ; Li, C; Yang, CS; Yang, GY | 1 |
Li, J; Zhang, Y; Zhou, L | 1 |
Arakawa, Y; Matsui, T; Sato, H | 1 |
Hara, Y; Ikigai, H; Okubo, S; Shimamura, T; Suzuki, T; Suzuki, Y; Toda, M | 1 |
Ebina, T; Tsukada, K | 1 |
38 review(s) available for catechin and Disease Models, Animal
Article | Year |
---|---|
Natural polyphenols in preclinical models of epilepsy.
Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Humans; Male; Polyphenols; Quercetin; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
Topics: Aberrant Crypt Foci; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Aspirin; Atorvastatin; Carcinogenesis; Catechin; Clinical Trials as Topic; Colon; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Mucosa; Lycopene; Mice; Mutation; Treatment Outcome | 2020 |
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Blood-Brain Barrier; Catechin; Cognition; Disease Models, Animal; Humans; Neuroprotective Agents; Phosphorylation | 2020 |
Beneficial Effects of Green Tea Catechins on Female Reproductive Disorders: A Review.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Proliferation; Corticosterone; Cross-Sectional Studies; Disease Models, Animal; Dysmenorrhea; Endometriosis; Female; Humans; Mice; Plant Extracts; Polycystic Ovary Syndrome; Tea; Uterus | 2021 |
The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Catechin; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Neuralgia | 2017 |
Beneficial Effects of Flavonoids Against Parkinson's Disease.
Topics: Animals; Anthocyanins; Antioxidants; Antiparkinson Agents; Catechin; Cell Line; Corpus Striatum; Disease Models, Animal; Dopamine; Flavanones; Flavones; Flavonoids; Flavonols; Humans; Isoflavones; Kaempferols; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2018 |
Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Epigenesis, Genetic; Glucose; Homeostasis; Humans; Lipid Metabolism; Muscle, Skeletal; NF-kappa B; Obesity; Oxidative Stress; Signal Transduction | 2019 |
Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Biological Availability; Catechin; Chemoprevention; Disease Models, Animal; Humans; Liver Neoplasms; Mice; Polyphenols; Tea; Xenograft Model Antitumor Assays | 2013 |
Polyphenols: benefits to the cardiovascular system in health and in aging.
Topics: Aging; Animals; Cardiovascular System; Catechin; Curcumin; Diet; Disease Models, Animal; Fruit; Heart Diseases; Humans; Olive Oil; Plant Oils; Polyphenols; Quercetin; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Resveratrol; Stilbenes | 2013 |
Prenatal treatment of Down syndrome: a reality?
Topics: Animals; Animals, Newborn; Apigenin; Catechin; Choline; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Fluoxetine; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Oxidative Stress; Pregnancy; Prenatal Care; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Stem Cell Transplantation | 2014 |
Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL.
Topics: Aggregatibacter actinomycetemcomitans; Animals; Apolipoproteins E; Atherosclerosis; Catechin; Disease Models, Animal; Humans; Inflammation; Mice; Oxidative Stress; Periodontal Diseases; Periodontium; Porphyromonas gingivalis | 2014 |
Dietary polyphenols regulate endothelial function and prevent cardiovascular disease.
Topics: Administration, Oral; Animals; Apigenin; Aryldialkylphosphatase; Cardiovascular Diseases; Catechin; Diet; Disease Models, Animal; Endothelial Cells; Endothelin-1; Humans; Lipoproteins, HDL; Nitric Oxide; Nitric Oxide Synthase Type III; Polyphenols; Signal Transduction; U937 Cells | 2015 |
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
Topics: Animals; Catechin; Cell Proliferation; Cucurbitacins; Curcumin; Disease Models, Animal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Neoplasms; Phytochemicals; Resveratrol; Signal Transduction; STAT Transcription Factors; Stilbenes | 2015 |
Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.
Topics: Alzheimer Disease; Animals; Catechin; Clinical Trials as Topic; Disease Models, Animal; Humans; Neuroprotective Agents; Oxidative Stress; Secondary Prevention; Treatment Outcome | 2017 |
Black tea: Phytochemicals, cancer chemoprevention, and clinical studies.
Topics: Amino Acids; Animals; Antimutagenic Agents; Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Chemoprevention; Clinical Studies as Topic; Disease Models, Animal; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Phytochemicals; Polyphenols; Tea; Volatile Organic Compounds | 2017 |
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss | 2016 |
Combination chemoprevention with grape antioxidants.
Topics: Animals; Anthocyanins; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Catechin; Cell Line, Tumor; Chemoprevention; Disease Models, Animal; Humans; Kaempferols; Neoplasms; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes; Vitis | 2016 |
Prevention and treatment of cancers by immune modulating nutrients.
Topics: Animals; Arginine; Catechin; Cell Line, Tumor; Diet; Disease Models, Animal; Fatty Acids, Unsaturated; Glutamine; Humans; Isothiocyanates; Lignans; Meta-Analysis as Topic; Micronutrients; Neoplasms; Observational Studies as Topic; Phytochemicals; Polyphenols; Randomized Controlled Trials as Topic; Stilbenes | 2016 |
Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.
Topics: Animals; Anticarcinogenic Agents; Biological Products; Catechin; Cell Line, Tumor; Chemoprevention; Curcumin; Disease Models, Animal; Humans; Nanoparticles; Nanotechnology; Neoplasms; Resveratrol; Stilbenes | 2016 |
Targeting cancer stem-like cells using dietary-derived agents - Where are we now?
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Curcumin; Diet; Disease Models, Animal; Flavonoids; Humans; Isothiocyanates; Neoplasms; Neoplastic Stem Cells; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Sulfoxides; Vitamin A | 2016 |
Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents.
Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Curcumin; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Food; Humans; Isothiocyanates; Phytochemicals; Resveratrol; Stilbenes; Sulfoxides | 2016 |
Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.
Topics: Animals; Antioxidants; Body Composition; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Meta-Analysis as Topic; Obesity; Oxidative Stress; Phytotherapy; Randomized Controlled Trials as Topic; Risk Factors; Tea | 2016 |
Anticancer Efficacy of Polyphenols and Their Combinations.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Biological Availability; Catechin; Cell Line, Tumor; Cell Proliferation; Curcumin; Disease Models, Animal; Humans; Micronutrients; Neoplasms; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes; Tea | 2016 |
Catechins and Its Role in Chronic Diseases.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Agents; Catechin; Chronic Disease; Disease Models, Animal; Drug Discovery; Humans; Molecular Structure; Neuroprotective Agents; Phytotherapy; Plant Extracts; Plants, Medicinal; Signal Transduction; Structure-Activity Relationship; Tea | 2016 |
Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state.
Topics: Animals; Apoptosis; Capsaicin; Catechin; Chemoprevention; Disease Models, Animal; Humans; Mitochondrial Membranes; Neoplasms; Permeability; Reactive Oxygen Species; Resveratrol; Stilbenes; Tea | 2009 |
Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Catechin; Disease Models, Animal; Flavonoids; Humans; Immunohistochemistry; Inflammation; Mice; Models, Biological; NF-kappa B; Nitric Oxide; Phenols; Polyphenols; Rats; Signal Transduction; Tea | 2009 |
Green tea and heart health.
Topics: Animals; Atherosclerosis; Camellia sinensis; Cardiovascular Diseases; Catechin; Cell Adhesion Molecules; Cytokines; Disease Models, Animal; Humans; Lipoproteins, LDL; Oxidation-Reduction; Tea | 2009 |
Tea, flavonoids and stroke in man and mouse.
Topics: Animals; Catechin; Disease Models, Animal; Flavonoids; Glutamates; Humans; Mice; Neuroprotective Agents; Stroke; Tea | 2010 |
[New perspectives on molecular and genic therapies in Down syndrome].
Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction | 2010 |
Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Diet; Disease Models, Animal; Fruit; Genistein; Humans; Neoplasms; Resveratrol; Signal Transduction; Silymarin; Stilbenes; United States; Vegetables | 2011 |
Cardiovascular effects of green tea catechins: progress and promise.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Catechin; Cell Proliferation; Clinical Trials as Topic; Disease Models, Animal; Fibrinolytic Agents; Humans; Inflammation; Models, Cardiovascular; Platelet Aggregation; Signal Transduction; Tea | 2012 |
Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
Topics: Alzheimer Disease; Animals; Antioxidants; Apoptosis; Catechin; Dietary Supplements; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Humans; Iron Chelating Agents; Neuroprotective Agents; Parkinson Disease; Phenols; Polyphenols; Signal Transduction; Tea | 2004 |
A review of the health effects of green tea catechins in in vivo animal models.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Catechin; Disease Models, Animal; Enzymes; Hormones; Kidney Diseases; Neoplasms, Experimental; Oxidative Stress; Tea | 2004 |
Chemoprevention of lung cancer by tea.
Topics: Animals; Antioxidants; Apoptosis; Catechin; Cell Division; Chemoprevention; Disease Models, Animal; Female; Flavonoids; Humans; Lung Neoplasms; Male; Phenols; Polyphenols; Tea; Tumor Necrosis Factor-alpha | 2006 |
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Topics: Acyl Coenzyme A; Animals; Catechin; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Multiple Sclerosis; Nerve Degeneration; Neuroprotective Agents; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand | 2007 |
Inhibition of carcinogenesis by tea constituents.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Transformation, Neoplastic; Disease Models, Animal; Flavonoids; Humans; Neoplasms; Phenols; Polyphenols; Tea | 2007 |
Tea and tea polyphenols in cancer prevention.
Topics: Animals; Biological Availability; Caffeine; Catechin; Disease Models, Animal; Flavonoids; Humans; Intestinal Absorption; Neoplasms; Phenols; Polymers; Structure-Activity Relationship; Tea; Tissue Distribution; Tumor Cells, Cultured | 2001 |
5 trial(s) available for catechin and Disease Models, Animal
Article | Year |
---|---|
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
Topics: Adult; Animals; Catechin; Cognition Disorders; Disease Models, Animal; Double-Blind Method; Female; Fragile X Syndrome; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neuroprotective Agents; Treatment Outcome; Young Adult | 2020 |
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
Topics: Adolescent; Adult; Animals; Biomarkers; Catechin; Chromosomes, Human, Pair 16; Cognition; Disease Models, Animal; Double-Blind Method; Down Syndrome; Dyrk Kinases; Female; Gene Expression Regulation; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Mosaicism; Phosphorylation; Pilot Projects; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Trisomy; Young Adult | 2014 |
The effect of procyanidin on expression of STAT1 in type 2 diabetes mellitus SD rats with focal cerebral ischemia.
Topics: Animals; Apoptosis; Biflavonoids; Brain Ischemia; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Janus Kinases; Male; Neuroprotective Agents; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor | 2014 |
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.
Topics: Adolescent; Animals; Autophagy; Biomarkers; Catechin; Child; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Drug Therapy, Combination; Homozygote; Humans; Interleukin-8; Lung; Mice; Mice, Knockout; Mutation; Sputum; Tumor Necrosis Factor-alpha | 2016 |
421 other study(ies) available for catechin and Disease Models, Animal
Article | Year |
---|---|
Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetylation; Animals; Benzofurans; Breast; Catechin; Cell Transformation, Neoplastic; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Indonesia; Isoenzymes; Membrane Proteins; Methylation; Mice; Mice, Inbred BALB C; Molecular Structure; Moraceae; Nuclear Magnetic Resonance, Biomolecular; Organ Culture Techniques; Plant Bark; Plant Extracts; Plant Shoots; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stilbenes | 2002 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Epigallocatechin gallate (EGCG) attenuates staphylococcal alpha-hemolysin (Hla)-induced NLRP3 inflammasome activation via ROS-MAPK pathways and EGCG-Hla interactions.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bacterial Proteins; Catechin; Disease Models, Animal; Hemolysin Proteins; Hemolysis; Humans; Inflammasomes; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; THP-1 Cells | 2021 |
Effect of (-)-Epigallocatechin Gallate on Activation of JAK/STAT Signaling Pathway by Staphylococcal Enterotoxin A.
Topics: Animals; Catechin; Cells, Cultured; Disease Models, Animal; Enterotoxins; Gene Expression Regulation, Bacterial; Humans; Janus Kinases; Mice; Signal Transduction; Spleen; Staphylococcus aureus; STAT3 Transcription Factor | 2021 |
Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2021 |
Alpinia officinarum water extract inhibits the atopic dermatitis-like responses in NC/Nga mice by regulation of inflammatory chemokine production.
Topics: Alpinia; Animals; Anti-Inflammatory Agents; Antigens, Dermatophagoides; Arthropod Proteins; Catechin; Chemokines; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Flavonoids; HaCaT Cells; Humans; Hydroxybenzoates; Keratinocytes; Male; Mice; Plant Extracts; Signal Transduction; Skin; Solvents; Water | 2021 |
EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis.
Topics: Animals; Autophagy; Catechin; Cells, Cultured; Disease Models, Animal; Dual-Specificity Phosphatases; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Silencing; Hydrogen Peroxide; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; RNA, Long Noncoding; Signal Transduction | 2021 |
Restorative potential of (-)-epicatechin in a rat model of Gulf War illness muscle atrophy and fatigue.
Topics: Animals; Catechin; Dietary Supplements; Disease Models, Animal; Fatigue; Humans; Male; Metabolome; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Persian Gulf Syndrome; Rats; Rats, Wistar | 2021 |
EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice.
Topics: Acetylation; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Catechin; Constriction; Disease Models, Animal; Electrocardiography; Heart Failure; Histone Deacetylases; Histones; Lysine; Male; MEF2 Transcription Factors; Natriuretic Peptide, Brain; Survival Rate; Ventricular Remodeling | 2022 |
Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model.
Topics: Animals; Antiviral Agents; Catechin; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Disease Models, Animal; Humans; Mice; Polyphenols; Tea; Virus Replication | 2021 |
Treg/Th17 Ratio Regulation May Play an Important Role in Epigallocatechin-3-Gallate-Mediated Attenuation of Increased Afterload-Induced Cardiac Hypertrophy.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Eosine Yellowish-(YS); Hematoxylin; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Th17 Cells; Wheat Germ Agglutinins | 2022 |
Synergistic alleviation effects of anchovy hydrolysates-catechin on scopolamine-induced mice memory deficits: the exploration of the potential relationship among gut-brain-axis.
Topics: Animals; Behavior, Animal; Catechin; Disease Models, Animal; Fish Oils; Fishes; Functional Food; Gastrointestinal Microbiome; Male; Memory Disorders; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Protein Hydrolysates; Scopolamine; Specific Pathogen-Free Organisms | 2022 |
Transcriptome analysis provides insight into the anti-diabetic mechanism of theaflavins in high-fat diet and streptozotocin-induced mice.
Topics: Animals; Antioxidants; Biflavonoids; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Expression Profiling; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Streptozocin; Tea | 2022 |
Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Energy Metabolism; Heart Failure; Myocardium; Rats; Reproducibility of Results | 2022 |
Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis.
Topics: Animals; Antimicrobial Peptides; Catechin; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Inflammation; Lipopolysaccharides; Mice; Nanomedicine; RAW 264.7 Cells | 2022 |
Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects.
Topics: Animals; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Heterografts; Humans; Mice; Polyphenols; Proline; Proline Oxidase; Tea; Triple Negative Breast Neoplasms | 2021 |
Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antioxidants; Brain-Derived Neurotrophic Factor; Catechin; Clomipramine; Depression; Disease Models, Animal; Hippocampus; Interleukin-1beta; Mice; RNA, Messenger; Stress, Psychological; Tea | 2022 |
HPLC-DAD analysis of Quercus leucotrichophora extract and appraisal of its antiasthmatic potential via modulation of aquaporins, inflammatory, and oxidative stress biomarkers in Albino mice.
Topics: Animals; Anti-Asthmatic Agents; Aquaporins; Asthma; Biomarkers; Bronchoalveolar Lavage Fluid; Catalase; Catechin; Chromatography, High Pressure Liquid; Dexamethasone; Disease Models, Animal; Glucuronic Acid; Immunoglobulin E; Interleukin-4; Lung; Malondialdehyde; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin; Oxidative Stress; Quercetin; Quercus; Superoxide Dismutase; Synthetic Drugs; Tumor Necrosis Factor-alpha | 2022 |
(-)-Epicatechin mitigates anxiety-related behavior in a mouse model of high fat diet-induced obesity.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Catechin; Diet, High-Fat; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Obesity; RNA, Ribosomal, 16S | 2022 |
Epigallocatechin-3-gallate alleviates galactose-induced aging impairment
Topics: Aging; Animals; Brain; Catechin; Disease Models, Animal; Galactose; Hypothalamo-Hypophyseal System; Mice; Pituitary-Adrenal System; Tea | 2022 |
Green Tea Catechins Modulate Skeletal Development with Effects Dependent on Dose, Time, and Structure in a down Syndrome Mouse Model.
Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Down Syndrome; Mice; Plant Extracts; Tea | 2022 |
Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia.
Topics: Animals; Bone Marrow; Catechin; Disease Models, Animal; Humans; Leukemia, Myeloid, Acute; Mice; Micelles; Sorafenib; Tea; Tissue Distribution | 2022 |
Effect of Alleviating Fibrosis with EGCG-Modified Bone Graft in Murine Model Depended on Less Accumulation of Inflammatory Macrophage.
Topics: Animals; Bone Regeneration; Capsules; Catechin; Disease Models, Animal; Durapatite; Macrophages; Mice; Osteogenesis | 2023 |
EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
Topics: Animals; Catechin; Disease Models, Animal; Mice; MicroRNAs; Myocardial Infarction; Myocardial Ischemia | 2023 |
The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.
Topics: Animals; Catechin; Disease Models, Animal; Estrogen Receptor beta; Estrogens; Humans; Neuroblastoma; Neuroprotective Agents; Parkinson Disease; Rats; Rotenone | 2023 |
Anti-Ulcerative Colitis Effects and Active Ingredients in Ethyl Acetate Extract from Decoction of
Topics: Animals; Catechin; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Toll-Like Receptor 4 | 2023 |
Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model.
Topics: Animals; Cardiopulmonary Resuscitation; Catechin; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Heart Arrest; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley | 2019 |
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Topics: Animals; Antiviral Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocyte Nuclear Factor 4; Humans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Virus Replication | 2020 |
Flavanol-rich lychee fruit extract substantially reduces progressive cognitive and molecular deficits in a triple-transgenic animal model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Catechin; Cognitive Dysfunction; Disease Models, Animal; Flavonoids; Fruit; Hippocampus; Humans; Litchi; Male; Mice; Mice, Transgenic; Mutation; Phenols; Phosphorylation; Plant Extracts; tau Proteins; Tea; Transgenes | 2021 |
Green Tea Polyphenol (-)-Epigallocatechin Gallate (EGCG) Attenuates Neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced Obese Mice.
Topics: Animals; Anti-Obesity Agents; Catechin; Cell Line; Diet, High-Fat; Disease Models, Animal; Hypothalamus; Inflammation; Interleukin-1beta; Interleukin-6; Janus Kinase 2; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Obese; Microglia; Obesity; Palmitic Acid; Polyphenols; STAT3 Transcription Factor; Tea; Tumor Necrosis Factor-alpha | 2019 |
Epigallocatechin 3-gallate attenuates arthritis by regulating Nrf2, HO-1, and cytokine levels in an experimental arthritis model.
Topics: Animals; Arthritis, Experimental; Catechin; Collagen Type II; Cytokines; Disease Models, Animal; Female; Heme Oxygenase (Decyclizing); NF-E2-Related Factor 2; Rats; Rats, Wistar | 2020 |
A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate.
Topics: Acute Disease; Animals; Antioxidants; Apoptosis; Aquaporin 2; Ascites; Catechin; Disease Models, Animal; Kidney; Liver; Liver Failure; Male; Membrane Transport Proteins; Mice; Urea Transporters | 2019 |
MicroRNA-384-5p/Beclin-1 As Potential Indicators For Epigallocatechin Gallate Against Cardiomyocytes Ischemia Reperfusion Injury By Inhibiting Autophagy Via PI3K/Akt Pathway.
Topics: Animals; Autophagy; Beclin-1; Catechin; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Humans; MicroRNAs; Molecular Structure; Myocardial Reperfusion Injury; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Structure-Activity Relationship | 2019 |
Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats.
Topics: Animals; Apoptosis; Behavior, Animal; Catechin; Corpus Striatum; Disease Models, Animal; Encephalitis; Inflammation Mediators; Male; Neuroprotective Agents; Parkinsonian Disorders; Rats, Wistar; Rotenone | 2020 |
Protective Effect of Epigallocatechin Gallate in Ischemia-Reperfusion Injury of Rat Skeletal Muscle.
Topics: Animals; Antioxidants; Catechin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Liver; Male; Muscle, Skeletal; Oxidative Stress; Rats; Reactive Oxygen Species; Reperfusion Injury | 2020 |
(-)-Catechin-7-
Topics: Animals; Catechin; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Male; Phosphorylation; Plant Bark; Plant Extracts; Protein Transport; Signal Transduction; STAT3 Transcription Factor; Ulmus | 2019 |
Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation.
Topics: Animals; Antioxidants; Catechin; Decanoic Acids; Disease Models, Animal; Fluorocarbons; Inflammasomes; Inflammation; Liver Diseases; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Polyphenols; Tea | 2020 |
Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis.
Topics: Adiponectin; Animals; Catechin; CD36 Antigens; Cholesterol, LDL; Disease Models, Animal; Fatty Liver; Fructose; Hepatocytes; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Perilipin-2; Perilipin-3; Perilipins; Risk Factors; Triglycerides; Uncoupling Protein 2 | 2020 |
Structural Characteristics and Hypolipidemic Activity of Theabrownins from Dark Tea Fermented by Single Species
Topics: Animals; Aspergillus; Catechin; Disease Models, Animal; Fermentation; Gas Chromatography-Mass Spectrometry; Hyperlipidemias; Molecular Weight; Obesity; Phenol; Plant Extracts; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tea; X-Ray Diffraction; Zebrafish | 2020 |
(-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model.
Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Brain Injuries, Traumatic; Catechin; Cerebral Cortex; Cognition; Cytokines; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Knockout; Morris Water Maze Test; Motor Activity; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Phosphorylation; Rotarod Performance Test; Signal Transduction | 2020 |
Procyanidin B3 alleviates intervertebral disc degeneration via interaction with the TLR4/MD-2 complex.
Topics: Animals; Anti-Inflammatory Agents; Biflavonoids; Catechin; Cell Death; Cell Survival; Disease Models, Animal; Disease Progression; Extracellular Matrix; Humans; Intervertebral Disc Degeneration; Lipopolysaccharides; Lymphocyte Antigen 96; Male; Myeloid Differentiation Factor 88; NF-kappa B; Nucleus Pulposus; Proanthocyanidins; Punctures; Rats, Sprague-Dawley; Signal Transduction; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4 | 2020 |
EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease.
Topics: Animals; Behavior, Animal; Catechin; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Female; Gastrointestinal Microbiome; Heat-Shock Proteins; Male; Mitochondria; Neuroprotective Agents; Parkinson Disease | 2020 |
Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Catechin; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Mutation; Neuroprotective Agents; Presenilin-1; Treatment Outcome | 2020 |
(-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Apoptosis; Catechin; Cells, Cultured; Disease Models, Animal; Fibroblasts; Hypertension; Malondialdehyde; Phytotherapy; Rats; Rats, Inbred Dahl; Receptors, Laminin; Sodium Chloride, Dietary | 2020 |
Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Catechin; Cerebral Infarction; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley | 2020 |
Efficacy of Topical Treatment with (-)-Epigallocatechin Gallate, A Green Tea Catechin, in Mice with Cutaneous Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Parasitic Sensitivity Tests; Tea | 2020 |
Green tea extract containing enhanced levels of epimerized catechins attenuates scopolamine-induced memory impairment in mice.
Topics: Animals; Avoidance Learning; Catechin; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Hot Temperature; Humans; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Plant Extracts; Scopolamine; Tea | 2020 |
Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability.
Topics: Animals; Catechin; Disease Models, Animal; Down Syndrome; Executive Function; Female; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nerve Net; Neuroprotective Agents; Prefrontal Cortex; Recognition, Psychology | 2020 |
(-)-Epicatechin mitigates high fat diet-induced neuroinflammation and altered behavior in mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Brain Diseases; Catechin; Diet, High-Fat; Disease Models, Animal; Flavonols; Hippocampus; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL | 2020 |
Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
Topics: Animals; Apoptosis; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Hepatocytes; Humans; Linoleic Acid; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2021 |
Epigallocatechin-3-gallate protects immunity and liver drug-metabolism function in mice loaded with restraint stress.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Biotransformation; Catechin; Cytochrome P-450 Enzyme System; Cytokines; Disease Models, Animal; Female; Immunoglobulin A, Secretory; Immunologic Factors; Inflammation Mediators; Isoenzymes; Liver; Male; Mice, Inbred ICR; Oxidative Stress; Restraint, Physical; Stress, Physiological; Stress, Psychological; T-Lymphocyte Subsets | 2020 |
Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice.
Topics: Administration, Oral; Animals; Body Weight; Cancellous Bone; Catechin; Disease Models, Animal; Down Syndrome; Femur; Maze Learning; Mice; Treatment Outcome; X-Ray Microtomography | 2020 |
Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease.
Topics: Acrylic Resins; Administration, Topical; Animals; Apoptosis; Catechin; Cell Line; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Dry Eye Syndromes; Female; Gelatin; Humans; Lectins; Ophthalmic Solutions; Oxidative Stress; Rabbits | 2020 |
Brain-targeted co-delivery of β-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Blood-Brain Barrier; Brain; Catechin; Disease Models, Animal; Humans; Mice; Mice, Transgenic; RNA, Small Interfering | 2020 |
Procyanidin B2 Improves Oocyte Maturation and Subsequent Development in Type 1 Diabetic Mice by Promoting Mitochondrial Function.
Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Membrane Potential, Mitochondrial; Mice, Inbred ICR; Mitochondria; Oocytes; Oxidative Stress; Proanthocyanidins; Reactive Oxygen Species; Streptozocin | 2020 |
Protection of procyanidin B2 on mitochondrial dynamics in sepsis associated acute kidney injury via promoting Nrf2 nuclear translocation.
Topics: Active Transport, Cell Nucleus; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Biflavonoids; Catechin; Disease Models, Animal; Kidney; Male; Mice, Inbred C57BL; Mitochondria; Mitochondrial Dynamics; Mitophagy; NF-E2-Related Factor 2; Oxidative Stress; Proanthocyanidins; Sepsis | 2020 |
Effects of EGCG on depression-related behavior and serotonin concentration in a rat model of chronic unpredictable mild stress.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Catechin; Colon; Depression; Disease Models, Animal; Hippocampus; Male; Open Field Test; Rats; Rats, Wistar; Serotonin; Stress, Psychological; Swimming | 2020 |
Chaetomium globosum extract mediated gold nanoparticle synthesis and potent anti-inflammatory activity.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Catechin; Chaetomium; Cyclooxygenase 2; Disease Models, Animal; Edema; Endophytes; Female; Gold; HeLa Cells; Humans; Hydrogen-Ion Concentration; Inflammation; Lipoxygenase; Male; Metal Nanoparticles; Mice; Plant Leaves; Vitex; Xanthine Oxidase | 2021 |
Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment.
Topics: Animals; Camellia sinensis; Catechin; Chromatography, Liquid; Cognition; Disease Models, Animal; Down Syndrome; Epigenesis, Genetic; Hippocampus; Mice; Mice, Transgenic; Phosphorylation; Plant Extracts; Protein Interaction Maps; Proteomics; Tandem Mass Spectrometry | 2020 |
Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Catechin; cdc25 Phosphatases; Cell Cycle; Cell Proliferation; Cell Survival; Diethylnitrosamine; Disease Models, Animal; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Transfection; Tumor Burden | 2020 |
Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues.
Topics: Adipose Tissue, White; Adiposity; Animals; Autophagy; Beclin-1; Catechin; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation, Developmental; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Obesity | 2020 |
(-)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin-proteasome system.
Topics: Animals; Catechin; Disease Models, Animal; Female; Magnetic Resonance Imaging; Muscle, Skeletal; Muscular Atrophy; Myofibrils; Proteasome Endopeptidase Complex; Rats, Long-Evans; Spinal Cord Injuries | 2020 |
Tissue distribution and molecular docking research on the active components of Bidens bipinnata L. against hyperlipidemia.
Topics: Animals; Bidens; Catechin; Chromatography, High Pressure Liquid; Disease Models, Animal; Drugs, Chinese Herbal; Gallic Acid; Hyperlipidemias; Linear Models; Liver; Molecular Docking Simulation; Rats; Reproducibility of Results; Rutin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2021 |
Anti-Melanogenesis Effects of Lotus Seedpod In Vitro and In Vivo.
Topics: Animals; Catechin; Disease Models, Animal; Lotus; Melanins; Mice; Mice, Inbred C57BL; Pigmentation Disorders; Plant Extracts; Seeds; Signal Transduction | 2020 |
Theaflavin ameliorates renal ischemia/reperfusion injury by activating the Nrf2 signalling pathway in vivo and in vitro.
Topics: Animals; Antioxidants; Apoptosis; Biflavonoids; Catechin; Cell Survival; Disease Models, Animal; Heme Oxygenase-1; Kidney; Kidney Diseases; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitochondria; NF-E2-Related Factor 2; Oxidative Stress; Reperfusion Injury; Signal Transduction; Up-Regulation | 2021 |
Epigallocatechin-3-gallate reduces liver and immune system damage in Acinetobacter baumannii-loaded mice with restraint stress.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Antioxidants; Catechin; Disease Models, Animal; Female; Immune System; Inflammation; Liver Diseases; Male; Mice; Mice, Inbred ICR; Oxidative Stress | 2021 |
Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.
Topics: Animals; Biomarkers; Brain; Catechin; Disease Models, Animal; Gliosis; Glucans; Hippocampus; Inclusion Bodies; Inflammation; Lafora Disease; Mice, Inbred C57BL; Mice, Knockout; Microglia; Motor Activity; Nerve Degeneration; Neurons; Phenotype; Propranolol; Ubiquitin-Protein Ligases | 2021 |
Epigallocatechin Gallate Ameliorates the Effects of Prenatal Alcohol Exposure in a Fetal Alcohol Spectrum Disorder-Like Mouse Model.
Topics: Animals; Astrocytes; Biomarkers; Catechin; Cell Differentiation; Disease Models, Animal; Doublecortin Protein; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Immunohistochemistry; Male; Maternal Exposure; Mice; Neurogenesis; Neurons; Oxidative Stress; Placenta; Pregnancy; Prenatal Exposure Delayed Effects | 2021 |
Theaflavin protects chondrocytes against apoptosis and senescence
Topics: Animals; Apoptosis; Biflavonoids; Catechin; Cells, Cultured; Cellular Senescence; Chondrocytes; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Osteoarthritis; Protective Agents | 2021 |
Epigallocatechin-3-gallate prevents inflammation and diabetes -Induced glucose tolerance through inhibition of NLRP3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Humans; Inflammasomes; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis | 2021 |
Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.
Topics: Adolescent; Animals; Catechin; Child; Child, Preschool; Dietary Supplements; Disease Models, Animal; Down Syndrome; Face; Female; Humans; Infant; Male; Mice; Plant Extracts; Tea | 2021 |
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.
Topics: Adipose Tissue; Animals; Body Weight; Catechin; Cholesterol; Diet, High-Fat; Disease Models, Animal; Lipids; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organ Size | 2021 |
Amelioration of N,N'-dimethylhydrazine induced colon toxicity by epigallocatechin gallate in Wistar rats.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Carcinogens; Catechin; Colonic Neoplasms; Disease Models, Animal; Humans; Male; Rats; Rats, Wistar | 2021 |
(-)-Epicatechin protects from amebic liver abscess development in hamster.
Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Catechin; Cricetinae; Cytokines; Dimethyl Sulfoxide; Disease Models, Animal; Liver; Liver Abscess, Amebic; Male; Mesocricetus; Metronidazole; Real-Time Polymerase Chain Reaction | 2021 |
Identification of regulated proteins by epigallocatechin gallate treatment in an ischemic cerebral cortex animal model: a proteomics approach.
Topics: Animals; Catechin; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Proteomics; Rats; Rats, Sprague-Dawley; Rodent Diseases | 2021 |
Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.
Topics: Animals; Apoptosis; Autophagy; Catechin; Diet, High-Fat; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mitogen-Activated Protein Kinases; Non-alcoholic Fatty Liver Disease; Signal Transduction | 2021 |
Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Catechin; Disease Models, Animal; Disease Progression; Male; Mental Health; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Risk Factors; Selenium; Vitamin E | 2021 |
Epigallocatechin-3-gallate attenuates acute pancreatitis induced lung injury by targeting mitochondrial reactive oxygen species triggered NLRP3 inflammasome activation.
Topics: Acute Lung Injury; Animals; Antioxidants; Catechin; Disease Models, Animal; DNA, Mitochondrial; Inflammasomes; Inflammation; Lung; Lung Injury; Male; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreatitis; Reactive Oxygen Species; Tea | 2021 |
First morphological-level insights into the efficiency of green tea catechins and grape seed procyanidins on a transgenic mouse model of celiac disease enteropathy.
Topics: Animals; Antioxidants; Biflavonoids; Catechin; Celiac Disease; Disease Models, Animal; Gliadin; Intestinal Diseases; Intestinal Mucosa; Male; Mice; Mice, Transgenic; Proanthocyanidins; Seeds; Tea; Vitis | 2021 |
Epicatechin treatment generates resilience to chronic mild stress-induced depression in a murine model.
Topics: Animals; Anxiety; Catechin; Depression; Depressive Disorder; Disease Models, Animal; Male; Mice; Stress, Psychological | 2021 |
Procyanidin B2 alleviates liver injury caused by cold stimulation through Sonic hedgehog signalling and autophagy.
Topics: Animals; Autophagy; Biflavonoids; Catechin; Cold Temperature; Disease Models, Animal; Hedgehog Proteins; Liver; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Proanthocyanidins; Signal Transduction | 2021 |
[Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Catechin; Disease Models, Animal; Hippocampus; Mice; Mice, Inbred ICR; Nanoparticles; Oligopeptides | 2021 |
(-)-Epicatechin ameliorates cigarette smoke-induced lung inflammation via inhibiting ROS/NLRP3 inflammasome pathway in rats with COPD.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cell Line; Disease Models, Animal; Epithelial Cells; Humans; Inflammasomes; Kelch-Like ECH-Associated Protein 1; Lung; Male; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pneumonia; Proteolysis; Pulmonary Disease, Chronic Obstructive; Pyroptosis; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Smoke; Tobacco Products; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2021 |
Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model.
Topics: Animals; Catechin; Conjunctiva; Cornea; Disease Models, Animal; Drug Therapy, Combination; Dry Eye Syndromes; Lacrimal Apparatus; Mice; Mice, Inbred NOD; Nanoparticles; Ophthalmic Solutions; Polyethylene Glycols; Surface-Active Agents; Tears; Treatment Outcome | 2017 |
Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Topics: Animals; Catechin; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2017 |
Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
Topics: Administration, Oral; Animals; Brain; Catechin; Cognition; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Femur; Male; Maze Learning; Mice, Inbred C3H; Mice, Transgenic; Motor Activity; Phenotype; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Random Allocation; Recognition, Psychology; Treatment Failure | 2017 |
PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Catechin; Cell Line, Tumor; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Drug Synergism; Fluorescent Antibody Technique; Gene Expression; Humans; Mice; Neoplastic Stem Cells; Phosphodiesterase 3 Inhibitors; Xenograft Model Antitumor Assays | 2017 |
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Catechin; Disease Models, Animal; Disks Large Homolog 4 Protein; Frontal Lobe; Hippocampus; Maze Learning; Memory Disorders; Mice; Motor Activity; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phosphorylation; Random Allocation; Spatial Memory; Synaptophysin; tau Proteins | 2017 |
Anti-inflammatory effect of epigallocatechin gallate in a mouse model of ovalbumin-induced allergic rhinitis.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Catechin; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Female; Histamine; Humans; Immunoglobulin E; Inflammation Mediators; Mice; Mice, Inbred BALB C; Ovalbumin; Rhinitis, Allergic; Sneezing; Tea | 2017 |
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model.
Topics: Amyloid; Amyloidogenic Proteins; Animals; Ataxin-3; Caenorhabditis elegans; Catechin; Disease Models, Animal; Humans; Hydrogen Bonding; Molecular Docking Simulation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Nuclear Proteins; Peptides; Phenols | 2017 |
Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Antioxidants; Catechin; Diet, High-Fat; Disease Models, Animal; Humans; Lipid Metabolism; Lipogenesis; Liver; Liver Function Tests; Male; Non-alcoholic Fatty Liver Disease; Phosphorylation; Polyphenols; Rats; Rats, Zucker; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Tea; Transcriptional Activation; Triglycerides; Up-Regulation; Weight Gain | 2017 |
Catechin attenuates traumatic brain injury-induced blood-brain barrier damage and improves longer-term neurological outcomes in rats.
Topics: Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Catechin; Disease Models, Animal; Inflammation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2017 |
Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Biomarkers; Catechin; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Humans; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; MicroRNAs; Mutation; Neuroblastoma; Presenilin-1; Protease Inhibitors; RNA, Messenger | 2017 |
Astilbe thunbergii reduces postprandial hyperglycemia in a type 2 diabetes rat model via pancreatic alpha-amylase inhibition by highly condensed procyanidins.
Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Hyperglycemia; Male; Proanthocyanidins; Rats; Saxifragaceae | 2017 |
Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.
Topics: Animals; Antioxidants; Axons; Catechin; Crush Injuries; Disease Models, Animal; Hyperalgesia; Male; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Oxidative Stress; Peripheral Nerve Injuries; Random Allocation; Rats, Wistar; Recovery of Function; RNA, Messenger; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord | 2017 |
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells.
Topics: Animals; Antineoplastic Agents; Catechin; Cation Transport Proteins; Cell Survival; Cells, Cultured; Copper; Copper Transport Proteins; Copper Transporter 1; Dextrans; Disease Models, Animal; Endothelial Cells; Heterografts; Homeostasis; Humans; Metallochaperones; Molecular Chaperones; Neoplasm Transplantation; Neovascularization, Pathologic; Neuroblastoma; Reactive Oxygen Species; Trace Elements; Treatment Outcome | 2017 |
(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease.
Topics: Animals; Atorvastatin; Catechin; Disease Models, Animal; Down-Regulation; Fibrillar Collagens; Gene Expression; Humans; Liver Cirrhosis; Male; Mice, Inbred C57BL; Multigene Family; Non-alcoholic Fatty Liver Disease | 2017 |
Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Epigenesis, Genetic; Estrogen Receptor alpha; Heterografts; Humans; Isothiocyanates; Mice; Neoplasm Transplantation; Phytochemicals; Sulfoxides; Tamoxifen; Treatment Outcome | 2017 |
Green tea supplementation produces better neuroprotective effects than red and black tea in Alzheimer-like rat model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Body Weight; Catechin; Disease Models, Animal; Hippocampus; Male; Memory; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Tea | 2017 |
Oligonol, a Low-Molecular Weight Polyphenol Derived from Lychee, Alleviates Muscle Loss in Diabetes by Suppressing Atrogin-1 and MuRF1.
Topics: Animals; Catechin; Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; Forkhead Box Protein O3; Fruit; Gene Expression Regulation; Litchi; Male; Mice; Mice, Inbred C57BL; Molecular Weight; Muscle Proteins; Muscle, Skeletal; NF-kappa B; Phenols; Polyphenols; RNA, Messenger; Sarcopenia; Sirtuin 1; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2017 |
Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Catechin; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; RNA, Messenger; Tea | 2017 |
Anti-oxidants correct disturbance of redox enzymes in the hearts of rat fetuses with congenital diaphragmatic hernia.
Topics: Acetophenones; Animals; Antioxidants; Catalase; Catechin; Disease Models, Animal; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hernias, Diaphragmatic, Congenital; Hydrogen Peroxide; Myocardium; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase | 2018 |
The cardioprotective effects of (-)-Epicatechin are mediated through arginase activity inhibition in a murine model of ischemia/reperfusion.
Topics: Animals; Arginase; Cardiotonic Agents; Catechin; Disease Models, Animal; Enzyme Inhibitors; Molecular Docking Simulation; Myocardium; Nitric Oxide Synthase; Protein Conformation; Reperfusion Injury | 2018 |
Protective effect of catechin on humoral and cell mediated immunity in rat model.
Topics: Animals; Carbon; Catechin; Cattle; Disease Models, Animal; Erythrocytes; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunity, Humoral; Immunomodulation; Male; Rats; Rats, Wistar | 2018 |
Epigallocatechin-3-gallate inhibits inflammation and epithelial‑mesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma.
Topics: Airway Remodeling; Animals; Asthma; Catechin; Disease Models, Animal; Epithelial-Mesenchymal Transition; Humans; Inflammation; Mice; Oncogene Protein v-akt; Ovalbumin; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Signal Transduction; Tea | 2018 |
EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the 'Active Oligomer' of α-Synuclein.
Topics: alpha-Synuclein; Amyloid; Animals; Catechin; Cell Membrane; Disease Models, Animal; Drosophila melanogaster; Electrophoresis, Polyacrylamide Gel; Microscopy, Electron, Transmission; Parkinson Disease | 2017 |
Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells.
Topics: Anaplastic Lymphoma Kinase; Animals; Blood Proteins; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Crizotinib; Disease Models, Animal; ErbB Receptors; Female; Gene Rearrangement; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oncogene Proteins, Fusion; Polyphenols; Protein S; Protein-Tyrosine Kinases; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Tea | 2017 |
Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogenesis; Carcinogens; Catechin; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Gastrointestinal Microbiome; Humans; Mice; Rectum; RNA, Ribosomal, 16S | 2017 |
The evaluation of the quality of Feng Huang Oolong teas and their modulatory effect on intestinal microbiota of high-fat diet-induced obesity mice model.
Topics: Adult; Altitude; Amino Acids; Animals; Catechin; Diet, High-Fat; Disease Models, Animal; Female; Gastrointestinal Microbiome; Humans; Male; Mice; Mice, Inbred C57BL; Obesity; Polyphenols; Tea | 2018 |
Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells.
Topics: Animals; Biomarkers, Tumor; Catechin; Cell Line, Tumor; Curcumin; Disease Models, Animal; Drug Combinations; Drug Synergism; Glioblastoma; Humans; Immunophenotyping; Killer Cells, Natural; Liposomes; Lymphocytes, Tumor-Infiltrating; Macrophages; Mice; Microglia; Neoplastic Stem Cells; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catechin; Disease Models, Animal; Dopaminergic Neurons; Immunomodulation; Male; Mice; Neuroprotective Agents; Parkinson Disease; T-Lymphocyte Subsets; Tyrosine 3-Monooxygenase | 2018 |
Phytochemical analysis and antibacterial activity of methanolic extract of Bergenia purpurascens against common respiratory infection causing bacterial species in vitro and in neonatal rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Bacteria; Benzopyrans; Catechin; Disease Models, Animal; Drugs, Chinese Herbal; Flavanones; Gallic Acid; Methanol; Microbial Sensitivity Tests; Phytochemicals; Plant Extracts; Plant Leaves; Rats; Respiratory Tract Infections; Saxifragaceae; Staphylococcal Infections; Staphylococcus aureus | 2018 |
EGCG Maintains Th1/Th2 Balance and Mitigates Ulcerative Colitis Induced by Dextran Sulfate Sodium through TLR4/MyD88/NF-
Topics: Animals; Catechin; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Intestinal Mucosa; Intestines; Male; Myeloid Differentiation Factor 88; Neuroprotective Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Spleen; Th1-Th2 Balance; Toll-Like Receptor 4 | 2017 |
Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats.
Topics: Age Factors; Aging; Animals; Antioxidants; Apoptosis; Cardiomyopathies; Catechin; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Lipids; Myocytes, Cardiac; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Effects of procyanidin on cardiomyocyte apoptosis after myocardial ischemia reperfusion in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Biflavonoids; Catechin; Creatine Kinase, MB Form; Cytoprotection; Disease Models, Animal; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Proanthocyanidins; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2018 |
Catechin Attenuates Coronary Heart Disease in a Rat Model by Inhibiting Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; Cardiovascular Agents; Catechin; Coronary Disease; Cytokines; Disease Models, Animal; Inflammation Mediators; Lipids; Myocytes, Cardiac; Rats, Wistar; Signal Transduction; Stroke Volume; Ventricular Function, Left | 2018 |
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
Topics: Animals; Apoptosis; Autophagy; Biomarkers; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Doxorubicin; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Neoplastic Stem Cells; Osteosarcoma; Receptor, Notch3; RNA, Long Noncoding; Xenograft Model Antitumor Assays | 2018 |
Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Memory Disorders; Memory, Short-Term; Mice; Mice, Mutant Strains; Williams Syndrome | 2018 |
Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways.
Topics: Animals; Apoptosis; Biomarkers; Catechin; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Female; Metabolic Syndrome; Mitochondria; Ovariectomy; Oxidative Stress; Plant Extracts; Primary Ovarian Insufficiency; Rats; Rats, Sprague-Dawley; Tea; Urinary Bladder, Overactive | 2018 |
Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
Topics: Animals; Apoptosis; Biomarkers; Catechin; Cytokines; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Male; Mice; Myocardium; Oxidative Stress; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ultrasonography | 2018 |
Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster.
Topics: Animals; Animals, Genetically Modified; Antioxidants; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Drosophila Proteins; Female; Herbicides; Lipid Peroxidation; Locomotion; Male; Minocycline; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Paraquat; Protein Deglycase DJ-1; Tyrosine 3-Monooxygenase | 2018 |
Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Anti-Obesity Agents; Catechin; Disease Models, Animal; Mice; RNA-Binding Proteins; RNA, Messenger; Tea | 2018 |
Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
Topics: Animals; Antibodies, Antinuclear; Biflavonoids; Catechin; Cells, Cultured; Disease Models, Animal; Female; Humans; Inflammasomes; Kidney; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; NLR Family, Pyrin Domain-Containing 3 Protein; Proanthocyanidins; RNA, Small Interfering; Signal Transduction | 2018 |
Against NF-κB/thymic stromal lymphopoietin signaling pathway, catechin alleviates the inflammation in allergic rhinitis.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Cells, Cultured; Cytokines; Disease Models, Animal; Epithelial Cells; Female; Humans; Immunoglobulin E; Inflammation; Interleukin-13; Interleukin-5; Mice; Mice, Inbred BALB C; NF-kappa B; Rhinitis, Allergic; Signal Transduction; Th1-Th2 Balance; Th2 Cells; Thymic Stromal Lymphopoietin | 2018 |
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa β-related pathway in rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Behavior, Animal; Biflavonoids; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries; Capillary Permeability; Catechin; Cerebral Hemorrhage; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transcription Factor RelA | 2018 |
Flavocoxid attenuates airway inflammation in ovalbumin-induced mouse asthma model.
Topics: Animals; Asthma; Biomarkers; Catechin; Disease Models, Animal; Drug Combinations; Inflammation; Lung; Mice; Ovalbumin; Oxidative Stress | 2018 |
Epigallocatechin-3-gallate protects against the exacerbation of allergic eosinophilic inflammation associated with obesity in mice.
Topics: Animals; Antioxidants; Asthma; Catechin; Disease Models, Animal; Eosinophils; Inflammation; Lung; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress | 2018 |
Theabrownin suppresses in vitro osteoclastogenesis and prevents bone loss in ovariectomized rats.
Topics: Animals; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Femur; Humans; Mice; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; RANK Ligand; Rats, Wistar; RAW 264.7 Cells | 2018 |
Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth.
Topics: Animals; Antineoplastic Agents, Phytogenic; B7-H1 Antigen; Catechin; Cell Line, Tumor; Disease Models, Animal; Gene Expression; Humans; Immunomodulation; Lung Neoplasms; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT1 Transcription Factor; T-Lymphocyte Subsets; Tea; Xenograft Model Antitumor Assays | 2018 |
Epigallocatechin Gallate Attenuates Bladder Dysfunction via Suppression of Oxidative Stress in a Rat Model of Partial Bladder Outlet Obstruction.
Topics: Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urinary Bladder Neck Obstruction | 2018 |
(-)-Epicatechin inhibits development of dilated cardiomyopathy in δ sarcoglycan null mouse.
Topics: Animals; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Catechin; Coronary Vessels; Disease Models, Animal; Fibrosis; Male; Mice, Knockout; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Sarcoglycans; Signal Transduction; TOR Serine-Threonine Kinases; Vasoconstriction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats.
Topics: Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Catechin; Crystallography, X-Ray; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Kidney; Microscopy, Electron, Transmission; Nanoparticles; Nephrotic Syndrome; Polymers; Powder Diffraction; Proteinuria; Rats, Sprague-Dawley; Renal Agents; Solubility | 2018 |
Epigallocatechin‑3‑gallate protects against secondary osteoporosis in a mouse model via the Wnt/β‑catenin signaling pathway.
Topics: Animals; beta Catenin; Calcium; Cartilage; Catechin; Cell Proliferation; Cyclin D1; Disease Models, Animal; Humans; Mice; Osteoporosis; PPAR gamma; Tea; Wnt Signaling Pathway | 2018 |
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
Topics: Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Catechin; Cerebral Infarction; Disease Models, Animal; Drug Compounding; Drug Liberation; Emulsions; Humans; Lipids; Male; Memory Disorders; Mice; Nanoparticles; Neuroprotective Agents; Treatment Outcome | 2019 |
Effects of Epigallocatechin Gallate on Behavioral and Cognitive Impairments, Hypothalamic-Pituitary-Adrenal Axis Dysfunction, and Alternations in Hippocampal BDNF Expression Under Single Prolonged Stress.
Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Humans; Male; Maze Learning; Memory; Pituitary-Adrenal System; Rats; Stress Disorders, Post-Traumatic; Stress, Physiological | 2018 |
Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice.
Topics: Acetylation; Animals; Aortic Diseases; Cardiovascular Agents; Catechin; Constriction, Pathologic; Disease Models, Animal; Heart Failure; Histone Deacetylase 1; Histones; Male; Mice, Inbred C57BL; Promoter Regions, Genetic; Protective Agents; Random Allocation; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Up-Regulation | 2018 |
(‑)Epigallocatechin‑3‑gallate attenuates anesthesia‑induced memory deficit in young mice via modulation of nitric oxide expression.
Topics: Anesthesia; Animals; Antioxidants; Apoptosis; Arginine; Biomarkers; Catechin; Disease Models, Animal; Indazoles; Male; Memory; Memory Disorders; Mice; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress | 2018 |
Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet.
Topics: Adipose Tissue, Brown; Animals; Biomarkers; Blood Glucose; Catechin; Cholesterol; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Hypothalamus; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microglia; NF-kappa B; Obesity; Polyphenols; STAT3 Transcription Factor; Tea; Triglycerides | 2018 |
Epicatechin alleviates inflammation in lipopolysaccharide-induced acute lung injury in mice by inhibiting the p38 MAPK signaling pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Biflavonoids; Catechin; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Proanthocyanidins; Protein Binding | 2019 |
G3BP1 promotes DNA binding and activation of cGAS.
Topics: Animals; Autoantigens; Autoimmune Diseases of the Nervous System; Catechin; Clustered Regularly Interspaced Short Palindromic Repeats; Cytosol; Disease Models, Animal; DNA; DNA Helicases; Exodeoxyribonucleases; HEK293 Cells; HeLa Cells; Humans; Interferons; Mice; Mice, Knockout; Multiprotein Complexes; Nervous System Malformations; Neuroprotective Agents; Nucleotidyltransferases; Phosphoproteins; Poly-ADP-Ribose Binding Proteins; Protein Binding; RNA Helicases; RNA Recognition Motif Proteins | 2019 |
Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.
Topics: Animals; Catechin; Cell Survival; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Epithelial Cells; Epithelium, Corneal; Gelatin; Humans; Hyaluronic Acid; Inflammation; Male; Nanoparticles; Ophthalmic Solutions; Particle Size; Rabbits; Rats; Sus scrofa; Tears; Treatment Outcome | 2018 |
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.
Topics: Amyloid Neuropathies, Familial; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Catechin; Disease Models, Animal; Drug Evaluation, Preclinical; Green Fluorescent Proteins; Humans; Locomotion; Longevity; Neuroprotective Agents; Prealbumin; Recombinant Fusion Proteins; Staining and Labeling | 2018 |
"Cell-addictive" dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Catechin; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Drug Carriers; Humans; Membrane Proteins; Mice; Molecular Targeted Therapy; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Protein Aggregation, Pathological; Treatment Outcome | 2018 |
Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Catechin; Cognitive Dysfunction; Coumaric Acids; Disease Models, Animal; Drug Therapy, Combination; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Presenilin-1 | 2019 |
Anti-inflammatory effects of new catechin derivatives in a hapten-induced mouse contact dermatitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catechin; Cytokines; Dermatitis, Allergic Contact; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Haptens; Mice; Mice, Inbred BALB C | 2019 |
Anti-arthritic and anti-inflammatory effects of (-)-Epicatechin-3-O-β-d-allopyranoside, a constituent of Davallia formosana.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Catechin; Collagen Type II; Cytokines; Disease Models, Animal; Edema; Ferns; Freund's Adjuvant; Glycosides; Immunoglobulin G; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred DBA; Nitric Oxide; Plant Extracts; RAW 264.7 Cells | 2019 |
Diet supplemented with phytochemical epigallocatechin gallate and probiotic Lactobacillus fermentum confers second generation synbiotic effects by modulating cellular immune responses and antioxidant capacity in aging mice.
Topics: Aging; Animals; Antioxidants; Catechin; Diet; Disease Models, Animal; Immunity, Cellular; Immunosenescence; Limosilactobacillus fermentum; Male; Mice; Oxidative Stress; Probiotics; Synbiotics | 2019 |
Theaflavins Improve Memory Impairment and Depression-Like Behavior by Regulating Microglial Activation.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Behavior, Animal; Biflavonoids; Catechin; Cells, Cultured; Depression; Disease Models, Animal; Memory; Mice; Microglia; Neuroprotective Agents; Tea | 2019 |
RNA-seq analysis of diet-driven obesity and anti-obesity effects of quercetin glucoside or epigallocatechin gallate in Drosophila adults.
Topics: Animals; Anti-Obesity Agents; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Glucosides; Humans; Lipid Metabolism; Male; Metabolomics; Obesity; Oxidative Stress; Quercetin; RNA-Seq; RNA, Messenger; Species Specificity | 2019 |
Tea's value as a cancer therapy is steeped in uncertainty.
Topics: Animals; Biological Products; Case-Control Studies; Catechin; Cell Line, Tumor; China; Cohort Studies; Dietary Supplements; Disease Models, Animal; Female; Humans; Incidence; Japan; Life Style; Male; Metabolic Syndrome; Mice; Neoplasms; Plant Extracts; Prostatic Neoplasms; Sex Factors; Smoking; Sunitinib; Tea; Uncertainty | 2019 |
Ingredients in Zijuan Pu'er Tea Extract Alleviate β-Amyloid Peptide Toxicity in a
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antioxidants; Biflavonoids; Caenorhabditis elegans; Caffeine; Catechin; Disease Models, Animal; Gene Expression Regulation; Humans; Oxidative Stress; Paralysis; Plant Extracts; Proanthocyanidins; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Tea | 2019 |
Green tea catechins alleviate autoimmune symptoms and visual impairment in a murine model for human chronic intraocular inflammation by inhibiting Th17-associated pro-inflammatory gene expression.
Topics: Animals; Catechin; Disease Models, Animal; Electroretinography; Inflammation; Interleukin-17; Interleukin-6; Mice; Microscopy, Confocal; Papilledema; Tea; Th17 Cells; Tomography, Optical Coherence; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders | 2019 |
Dietary supplementation with procyanidin-rich Pinus pinaster extract is associated with attenuated Ehrlich tumor development in mice.
Topics: Animals; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Dietary Supplements; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Pinus; Plant Extracts; Proanthocyanidins | 2019 |
(-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury.
Topics: Animals; Antioxidants; Biomarkers; Catechin; Chaperonin 60; Disease Models, Animal; Hepatic Veno-Occlusive Disease; Inflammation Mediators; Liver; Male; Mice; Mice, Transgenic; Models, Molecular; Molecular Conformation; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship | 2019 |
Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease
Topics: Animals; Bacteroidetes; Biflavonoids; Biomarkers; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Insulin Resistance; Lipopolysaccharides; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Proanthocyanidins; Protective Agents; Rabbits; RNA, Ribosomal, 16S; Treatment Outcome; Triglycerides | 2019 |
Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway.
Topics: Angiopoietin-Like Protein 4; Animals; Antioxidants; Apoptosis; Blotting, Western; Catechin; Disease Models, Animal; Doxorubicin; Fluorescent Antibody Technique; Glomerulosclerosis, Focal Segmental; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2019 |
(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway.
Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Long-Term Potentiation; Male; Neurons; Neuroprotective Agents; NF-kappa B; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Signal Transduction; Toll-Like Receptor 4 | 2019 |
Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.
Topics: Animals; Brain; Catechin; Cognition; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Glutamate Decarboxylase; Interneurons; Maternal-Fetal Exchange; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pregnancy; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Tea | 2019 |
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Ascorbic Acid; Brain; Catechin; Disease Models, Animal; Drug Carriers; Drug Liberation; Endothelial Cells; Male; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats | 2019 |
Avocado seeds (Persea americana Mill.) prevents indomethacin-induced gastric ulcer in mice.
Topics: Animals; Antioxidants; Brazil; Catechin; Chromatography, High Pressure Liquid; Disease Models, Animal; Flavonoids; Indomethacin; Lipid Peroxidation; Male; Mice; Oxidation-Reduction; Persea; Phenols; Plant Extracts; Seeds; Stomach Ulcer; Superoxide Dismutase | 2019 |
Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
Topics: Animals; Antioxidants; Biomarkers; Bleomycin; Catalase; Catechin; Disease Models, Animal; Glutathione Peroxidase; Hydroxyproline; Inflammation; Lung; Male; Malondialdehyde; Mice; Oxidative Stress; Protective Agents; Pulmonary Fibrosis; Superoxide Dismutase | 2019 |
Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Catechin; Disease Models, Animal; Female; Forkhead Transcription Factors; Immunoglobulin E; Interleukin-10; Interleukin-17; Lung; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.
Topics: Adaptor Proteins, Signal Transducing; Aged; Alzheimer Disease; Animals; Axin Protein; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Down-Regulation; Dyrk Kinases; Female; HEK293 Cells; HeLa Cells; Hippocampus; Humans; Male; Mice; Middle Aged; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA-Seq; Wnt Signaling Pathway | 2019 |
Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein.
Topics: Animals; Anticholesteremic Agents; Biological Transport, Active; Caffeine; Catechin; Cholesterol; Disease Models, Animal; Dyslipidemias; Feeder Cells; Gastrointestinal Microbiome; Hep G2 Cells; Humans; Kaempferols; Lipid Metabolism; Lipoproteins, VLDL; Litsea; Liver; Male; Models, Biological; Quercetin; Rats; Rats, Sprague-Dawley; Receptors, LDL; Sterol Regulatory Element Binding Protein 2; Teas, Medicinal | 2019 |
Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis.
Topics: Animals; Caspase 1; Catechin; Disease Models, Animal; DNA, Mitochondrial; Gout; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Uric Acid | 2019 |
(-)-Epicatechin reduces adiposity in male offspring of obese rats.
Topics: Adiposity; Animals; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Female; Humans; Insulin Resistance; Leptin; Male; Obesity, Maternal; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 2020 |
Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation.
Topics: Acute Lung Injury; Animals; Catechin; Disease Models, Animal; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2019 |
Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Macrophages; Male; Mice, Inbred C57BL; Permeability; T-Lymphocytes | 2019 |
Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Catechin; Choline O-Acetyltransferase; Cognition Disorders; Disease Models, Animal; Glutathione; Hippocampus; Interleukin-1beta; Male; Maze Learning; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Streptozocin; Tumor Necrosis Factor-alpha | 2013 |
Protective effects of a catechin-rich extract on the hippocampal formation and spatial memory in aging rats.
Topics: Age Factors; Animals; Catechin; Dendrites; Disease Models, Animal; Hippocampus; Lysosomes; Male; Malondialdehyde; Maze Learning; Memory Disorders; Microscopy, Electron, Transmission; Mitochondria; Neuroprotective Agents; Protein Carbonylation; Pyramidal Cells; Random Allocation; Rats; Rats, Wistar; Silver Staining; Space Perception | 2013 |
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.
Topics: Animals; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Intima-Media Thickness; Catechin; Cell Proliferation; Disease Models, Animal; Disulfides; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Injections, Intraperitoneal; Isothiocyanates; Male; Neointima; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfinic Acids; Sulfoxides; Time Factors | 2013 |
Beneficial effects of green tea catechin on massive hepatectomy model in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; Catechin; Cell Count; Cyclooxygenase 2; Disease Models, Animal; Free Radical Scavengers; Hepatectomy; Kupffer Cells; L-Lactate Dehydrogenase; Liver; Liver Regeneration; Male; Malondialdehyde; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Phytotherapy; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Tea; Tumor Necrosis Factor-alpha | 2014 |
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Bacteroidaceae Infections; Biomarkers; Catechin; Disease Models, Animal; Gene Expression Profiling; Male; Mice; Mice, Knockout; Porphyromonas gingivalis; Tea Tree Oil; Treatment Outcome | 2013 |
[Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Disease Models, Animal; Female; Galactose; Gene Expression Regulation; Hippocampus; Mice; Neurons; Neuroprotective Agents; Phytotherapy; Tea | 2012 |
Effect of dietary polyphenols from hop (Humulus lupulus L.) pomace on adipose tissue mass, fasting blood glucose, hemoglobin A1c, and plasma monocyte chemotactic protein-1 levels in OLETF rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Fasting; Glucosephosphate Dehydrogenase; Humulus; Malate Dehydrogenase; Male; Rats; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2013 |
(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blotting, Western; Catechin; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Immunohistochemistry; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Phosphorylation; Presenilin-1; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.
Topics: Adenomyosis; Animals; Biomarkers; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrocortisone; Hyperalgesia; Mice; Mice, Inbred ICR; Myometrium; Pain Threshold; Reaction Time; Stress, Physiological; Tamoxifen; Time Factors; Uterine Contraction | 2013 |
Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats.
Topics: Animals; Aquaporin 4; Blotting, Western; Catechin; Disease Models, Animal; Edema; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 2013 |
Extract of Ulmus macrocarpa Hance prevents thrombus formation through antiplatelet activity.
Topics: Adenosine Diphosphate; Animals; Catechin; Chromatography, High Pressure Liquid; Collagen; Disease Models, Animal; Fibrinolytic Agents; Male; Plant Extracts; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Thrombosis; Ulmus | 2013 |
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Disease Models, Animal; Exosomes; Female; Gene Expression Regulation, Neoplastic; I-kappa B Kinase; I-kappa B Proteins; Macrophage Colony-Stimulating Factor; Macrophages; Mice; MicroRNAs; Paracrine Communication | 2013 |
Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress.
Topics: Animals; Apoptosis; Caspase 12; Catechin; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Endoplasmic Reticulum Stress; Flavonoids; Heat-Shock Proteins; Male; Mitogen-Activated Protein Kinase Kinases; Neuroprotective Agents; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Spectrin; Stroke; Transcription Factor CHOP; TRPC Cation Channels | 2014 |
Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model.
Topics: Animals; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Mitomycin; Neoplasms, Experimental; Rats; Urinary Bladder Neoplasms | 2014 |
Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Type 1; Disease Models, Animal; Down-Regulation; Epithelial Cells; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Salivary Glands; Sjogren's Syndrome; Tumor Suppressor Protein p53; Xerostomia | 2014 |
Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice.
Topics: Animals; Catechin; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Male; Mice, Inbred C57BL; Oxidative Stress; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2014 |
Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2.
Topics: Animals; Antioxidants; Apoptosis; Autoantigens; Autoimmune Diseases; Catechin; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Heme Oxygenase-1; Mice; Mice, Inbred MRL lpr; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Severity of Illness Index; Sialadenitis; Submandibular Gland | 2014 |
Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Catechin; Chemokines; Corn Oil; Cytokines; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Diet, High-Fat; Dietary Fats; Dietary Supplements; Disease Models, Animal; Inflammation; Leukocytes; Male; Malondialdehyde; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Wistar | 2013 |
Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors.
Topics: Animals; Blood Glucose; Blood Pressure; Catechin; Diet, High-Fat; Disease Models, Animal; Eating; Energy Metabolism; Feces; Heart Diseases; Male; Obesity; Rats; Rats, Wistar; Risk Factors; Triglycerides; Weight Gain | 2014 |
Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.
Topics: Adenocarcinoma; Animals; Catechin; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Safety | 2014 |
Epigallocatechin-3-gallate restores the Bcl-2 expression in liver of young rats challenged with hypercholesterolemia but not in aged rats: an insight into its disparity of efficacy on advancing age.
Topics: Age Factors; Animals; Apoptosis; Catechin; Disease Models, Animal; Humans; Hypercholesterolemia; Liver; Male; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2014 |
Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antioxidants; Blotting, Western; Catechin; Cornea; Corneal Neovascularization; Cyclooxygenase 2; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Ophthalmic Solutions; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2014 |
Effect of epicatechin gallate dietary supplementation on transgenic Drosophila model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Antioxidants; Apoptosis; Brain; Camellia sinensis; Catechin; Dietary Supplements; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drosophila melanogaster; Drosophila Proteins; Humans; Lipid Peroxidation; Locomotion; Oxidative Stress; Parkinson Disease; Phytotherapy; Plant Extracts | 2014 |
(-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress.
Topics: Animals; Antioxidants; Blotting, Western; Catechin; Dietary Supplements; Disease Models, Animal; Endoplasmic Reticulum Stress; Fructose; Insulin Resistance; Male; Metabolic Syndrome; Oxidation-Reduction; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Signal Transduction | 2014 |
(-)-Epigallocatechin-3-gallate attenuated myocardial mitochondrial dysfunction and autophagy in diabetic Goto-Kakizaki rats.
Topics: Animals; Autophagy; Catechin; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mitochondria, Heart; Oxidative Stress; Rats; Rats, Wistar | 2014 |
Identification of epicatechin as one of the key bioactive constituents of polyphenol-enriched extracts that demonstrate an anti-allergic effect in a murine model of food allergy.
Topics: Animals; Anti-Allergic Agents; Biological Availability; Catechin; Chymases; Cytokines; Disease Models, Animal; Female; Food Hypersensitivity; Fruit; Gene Expression; Immunoglobulin E; Immunoglobulin G; Intestine, Small; Lymph Nodes; Malus; Mesentery; Mice; Mice, Inbred BALB C; Ovalbumin; Plant Extracts; Polyphenols | 2014 |
(-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury.
Topics: Animals; bcl-X Protein; Catechin; Disease Models, Animal; GAP-43 Protein; Immunohistochemistry; Male; Nerve Crush; Nerve Degeneration; Neuroprotective Agents; Peripheral Nerve Injuries; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; Sciatic Nerve; Spinal Cord | 2015 |
Amelioration of lipid profile and level of antioxidant activities by epigallocatechin-gallate in a rat model of atherogenesis.
Topics: Animals; Antioxidants; Atherosclerosis; Catechin; Diet, Atherogenic; Disease Models, Animal; Lipids; Male; Rats; Rats, Wistar | 2014 |
Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
Topics: Amyloid; Animals; Ataxin-3; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Catechin; Cell Survival; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Gene Expression; Green Fluorescent Proteins; Humans; Hydrogen Bonding; Machado-Joseph Disease; Microscopy, Atomic Force; Nerve Tissue Proteins; Neuroprotective Agents; Protein Aggregates; Recombinant Fusion Proteins; Spectroscopy, Fourier Transform Infrared; Tetracycline | 2014 |
Green tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis.
Topics: Animals; Aqueous Humor; Catechin; Disease Models, Animal; Endotoxins; Inflammation; Lipopolysaccharides; Neutrophil Infiltration; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Uveitis | 2014 |
The therapeutic effects of EGCG on vitiligo.
Topics: Animals; Anti-Inflammatory Agents; Catechin; CD8-Positive T-Lymphocytes; Disease Models, Animal; Female; Hydroquinones; Interferon-gamma; Interleukin-6; Melanocytes; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Skin Pigmentation; Transcriptome; Tumor Necrosis Factor-alpha; Vitiligo | 2014 |
Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
Topics: Animals; Antipsychotic Agents; Caffeine; Catalepsy; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Lipid Peroxidation; Male; Mice; Motor Activity; Parkinsonian Disorders; Tea | 2015 |
Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Awareness; Brain; Catechin; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Fruit; Kidney; Lipid Peroxidation; Liver; Male; Maze Learning; Memory; Memory Disorders; Mice, Inbred ICR; Nitric Oxide; Peptide Fragments; Phenols; Phytotherapy; Plant Extracts; Recognition, Psychology | 2014 |
Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cisplatin; Disease Models, Animal; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL | 2014 |
[Effects of EGCG on learning and memory ability expression level of NMDA receptor NR1 subunit protein in the brain of fatigue rats].
Topics: Animals; Catechin; Disease Models, Animal; Fatigue; Learning; Male; Memory; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2014 |
Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anxiety; Catechin; Cerebral Cortex; Disease Models, Animal; Drinking Water; Female; Hippocampus; Housing, Animal; Humans; Male; Maze Learning; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nootropic Agents; Peptide Fragments | 2015 |
(-)-Epicatechin prevents alterations in the metabolism of superoxide anion and nitric oxide in the hearts of L-NAME-treated rats.
Topics: Animals; Antihypertensive Agents; Catechin; Coronary Vessels; Dietary Supplements; Disease Models, Animal; Enzyme Activation; Fruit; Heart Ventricles; Hypertension; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Rats, Sprague-Dawley; Stereoisomerism; Superoxides; Vegetables | 2015 |
Novel Epigenetic Regulation of Alpha-Synuclein Expression in Down Syndrome.
Topics: alpha-Synuclein; Animals; Catechin; Disease Models, Animal; DNA Methylation; Down Syndrome; Epigenesis, Genetic; Mice; Promoter Regions, Genetic | 2016 |
Anti-allergic effect of intranasal administration of type-A procyanidin polyphenols based standardized extract of cinnamon bark in ovalbumin sensitized BALB/c mice.
Topics: Administration, Intranasal; Animals; Anti-Allergic Agents; Biflavonoids; Catechin; Cinnamomum zeylanicum; Disease Models, Animal; Histamine; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Plant Bark; Plant Extracts; Polyphenols; Proanthocyanidins; Rhinitis, Allergic; Sneezing | 2015 |
Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse post-traumatic osteoarthritis model.
Topics: Animals; Anti-Inflammatory Agents; Cartilage, Articular; Catechin; Chondrocytes; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Osteoarthritis; Palliative Care; Polyphenols; Tea | 2014 |
Hippocampal Neuroprotection by Minocycline and Epigallo-Catechin-3-Gallate Against Cardiopulmonary Bypass-Associated Injury.
Topics: Adenosine Triphosphate; Animals; Apoptosis Inducing Factor; Brain Edema; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Cardiopulmonary Bypass; Caspase 3; Catechin; Chromatography, High Pressure Liquid; Disease Models, Animal; Hypoxia-Inducible Factor 1, alpha Subunit; Minocycline; Neuroprotective Agents; Poly Adenosine Diphosphate Ribose; Swine; Tyrosine | 2015 |
Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.
Topics: Animals; Bilirubin; Catechin; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Heme Oxygenase-1; Inflammation; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Ureteral Obstruction | 2015 |
(-) Epigallocatechin-3-gallate attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
Topics: Animals; Catalase; Catechin; Corpus Striatum; Disease Models, Animal; Glutathione; Lipid Peroxidation; Male; Movement Disorders; Oxidative Stress; Rats; Rats, Wistar; Reserpine; Superoxide Dismutase | 2015 |
Epigallocatechin-3-gallate protects against cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Caspase 12; Catechin; Cisplatin; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Extracellular Signal-Regulated MAP Kinases; Heat-Shock Proteins; Kidney; Male; Mice; Mice, Inbred C57BL; Phosphorylation | 2015 |
Effect of epigallocatechin gallate on uncoupling protein 2 in acute liver injury.
Topics: Animals; Antioxidants; Catechin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ion Channels; Male; Mitochondrial Proteins; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Thioacetamide; Uncoupling Protein 2 | 2015 |
Anti-atherosclerotic activity of catechins depends on their stereoisomerism.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Catechin; Cholesterol, HDL; Disease Models, Animal; Hypolipidemic Agents; Male; Mice, Knockout; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Thiobarbituric Acid Reactive Substances; Triglycerides; Weight Gain | 2015 |
Epigallocatechin-3-gallate attenuates lipopolysaccharide-induced mastitis in rats via suppressing MAPK mediated inflammatory responses and oxidative stress.
Topics: Animals; Blotting, Western; Catechin; Disease Models, Animal; Female; Lipopolysaccharides; Male; Mammary Glands, Animal; Mastitis; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Pregnancy; Rats, Sprague-Dawley | 2015 |
Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
Topics: Animals; Aquaporin 5; Autoimmune Diseases; Catechin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Gene Expression Regulation; Histone Deacetylase 1; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred MRL lpr; NF-kappa B; Protein Subunits; Reactive Oxygen Species; Salivary Glands; Sialadenitis; Submandibular Gland | 2015 |
[Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea].
Topics: Alkalies; Animals; Burns, Chemical; Catechin; Cornea; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Inflammation; Mice; Mice, Inbred C57BL; Neutrophils; RNA, Messenger; Vascular Endothelial Growth Factor A | 2015 |
[Anti-Candida activity of aroma candy and its protective activity against murine oral candidiasis].
Topics: Acyclic Monoterpenes; Animals; Candida albicans; Candidiasis, Oral; Candy; Cassia; Catechin; Codonopsis; Decanoic Acids; Disease Models, Animal; Drug Combinations; Drug Resistance, Fungal; Fatty Acids; Glycyrrhiza; Maltose; Mice; Mice, Inbred ICR; Monoterpenes; Phenols; Plant Extracts; Polyphenols; Propolis; Specific Pathogen-Free Organisms; Starch; Sugar Alcohols; Treatment Outcome | 2015 |
(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression.
Topics: Alzheimer Disease; Animals; Catechin; Cell Proliferation; Cells, Cultured; CHO Cells; Cognition Disorders; Cricetulus; Disease Models, Animal; Mice; Neprilysin; Stereoisomerism; Up-Regulation | 2015 |
Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
Topics: Animals; Biomarkers; Blood Glucose; Camellia sinensis; Catechin; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulysin; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plants, Medicinal; Time Factors | 2015 |
Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation.
Topics: Animals; Bile Ducts, Intrahepatic; Catechin; Cell Death; Cholestasis; Cytokines; Disease Models, Animal; Gene Expression Regulation; Hepatic Stellate Cells; Hepatocytes; Inflammation; Liver Cirrhosis; Mice; Mitochondria; NF-kappa B; Oxidative Stress | 2015 |
Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Catechin; Choline Deficiency; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Inflammation Mediators; Lipids; Liver; Male; Methionine; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Signal Transduction; Transforming Growth Factor beta | 2015 |
Nodulisporiviridins A-H, Bioactive Viridins from Nodulisporium sp.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Androstenes; Animals; Bacteriocins; Catechin; China; Crystallography, X-Ray; Disease Models, Animal; Humans; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Xylariales | 2015 |
Biochemical and histopathological effects of catechin on experimental peripheral nerve injuries.
Topics: Animals; Catechin; Disease Models, Animal; Male; Neuroprotective Agents; Peripheral Nerve Injuries; Rats; Rats, Wistar | 2015 |
Protective effects of epigallocatechin-3-gallate on intestinal ischemia reperfusion injury through enhanced activation of PI3K/Akt pathway in rats.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Disease Models, Animal; Gene Expression Regulation; Interleukin-1; Interleukin-6; Intestines; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Blood Pressure; Catechin; Cytokines; Disease Models, Animal; Hypertension, Renovascular; Infusions, Parenteral; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Rats, Sprague-Dawley; Superoxide Dismutase-1; Time Factors | 2016 |
Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a.
Topics: Animals; Bone Diseases; Catechin; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Gene Dosage; Male; Mice; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2015 |
Procyanidin B2 attenuates neurological deficits and blood-brain barrier disruption in a rat model of cerebral ischemia.
Topics: Animals; Biflavonoids; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Catechin; Disease Models, Animal; Glutathione Transferase; Heme Oxygenase-1; Inactivation, Metabolic; Infarction, Middle Cerebral Artery; Isoenzymes; Male; NAD(P)H Dehydrogenase (Quinone); Neuroprotective Agents; Oxidative Stress; Permeability; Proanthocyanidins; Rats, Sprague-Dawley; Tight Junctions | 2015 |
Protective Effects of Catechin against Monosodium Urate-Induced Inflammation through the Modulation of NLRP3 Inflammasome Activation.
Topics: Animals; Calcium; Carrier Proteins; Catechin; Disease Models, Animal; Free Radical Scavengers; Gallic Acid; Inflammasomes; Inflammation; Interleukin-1beta; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Peritonitis; Protective Agents; Uric Acid | 2015 |
[Study on inhibitory effect of EGCG on Calcium oxalate nephrolithiasis in rats and its related mechanism].
Topics: Animals; Blood Urea Nitrogen; Calcium; Calcium Oxalate; Catechin; Creatinine; Disease Models, Animal; Humans; Kidney; Male; Nephrolithiasis; Osteopontin; Rats; Rats, Wistar | 2015 |
EGCG induces G-CSF expression and neutrophilia in experimental sepsis.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Cells, Cultured; Chemokines; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; HMGB1 Protein; Humans; Leukocytes, Mononuclear; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Neutrophils; Sepsis; Tea | 2015 |
Epicatechin Reduces Striatal MPP⁺-Induced Damage in Rats through Slight Increases in SOD-Cu,Zn Activity.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Catechin; Copper; Disease Models, Animal; Male; Rats; Rats, Wistar; Zinc | 2015 |
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antiviral Agents; Broadly Neutralizing Antibodies; Catechin; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hepatitis C; Hepatitis Viruses; Humans; Liver; Mice, SCID; Time Factors | 2016 |
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carrier Proteins; Catechin; Disease Models, Animal; Ferredoxin-NADP Reductase; Humans; Inositol; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Oligopeptides; Protein Aggregation, Pathological; Taurine | 2015 |
Dressing with epigallocatechin gallate nanoparticles for wound regeneration.
Topics: Animals; Anti-Bacterial Agents; Bandages; Biocompatible Materials; Catechin; Cells, Cultured; Chitosan; Disease Models, Animal; Drug Delivery Systems; Fibroblasts; Gelatin; Gentamicins; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Materials Testing; Nanoparticles; Polyglutamic Acid; Rats; Rats, Sprague-Dawley; Re-Epithelialization; Wound Healing; Wounds and Injuries | 2016 |
Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Blotting, Western; Catechin; Disease Models, Animal; Female; Fibroblasts; Humans; Immunoprecipitation; In Vitro Techniques; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Interleukin-6; Interleukin-8; Lysine; MAP Kinase Kinase Kinases; Molecular Docking Simulation; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Rats; Rats, Inbred Lew; Synovial Membrane; TNF Receptor-Associated Factor 6; Ubiquitination | 2016 |
Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure.
Topics: Adenine; Animals; Catechin; CHO Cells; Creatinine; Cresols; Cricetinae; Cricetulus; Disease Models, Animal; Glucuronides; HEK293 Cells; Humans; Indican; Kidney; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Sulfates; Sulfuric Acid Esters; Tea; Toxins, Biological | 2015 |
Green Tea Polyphenol Prevents Diabetic Rats From Acute Kidney Injury After Cardiopulmonary Bypass.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Biopsy, Needle; Cardiopulmonary Bypass; Catechin; Diabetes Mellitus, Experimental; Disease Models, Animal; Follow-Up Studies; Immunohistochemistry; Kidney Function Tests; Male; Polyphenols; Preoperative Care; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reference Values; Risk Assessment; Tea; Treatment Outcome | 2016 |
Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model.
Topics: Absorptiometry, Photon; Animals; Bone and Bones; Catechin; Dietary Supplements; Disease Models, Animal; Down Syndrome; Female; Femur; Male; Mice, Inbred C57BL; Mice, Mutant Strains; X-Ray Microtomography | 2016 |
Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Catechin; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Neuroprotective Agents; Permeability; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Sensory Gating; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2016 |
The Effect of Epigallocatechin Gallate on Flap Viability of Rat Perforator Abdominal Flaps.
Topics: Abdomen; Angiogenesis Inducing Agents; Animals; Catechin; Disease Models, Animal; Female; Graft Survival; Perforator Flap; Plastic Surgery Procedures; Rats; Rats, Wistar; Regional Blood Flow | 2016 |
Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats.
Topics: Animals; Arginine; Catechin; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Glutathione; Hippocampus; Lipid Peroxidation; Male; Memory Disorders; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Reserpine; Signal Transduction; Smell; Superoxide Dismutase | 2016 |
Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling.
Topics: Animals; Antioxidants; Arthritis, Experimental; Autoimmune Diseases; Catechin; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Male; Mice; Mice, Inbred DBA; Mice, Knockout; Osteoclasts; Osteogenesis; Signal Transduction; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells | 2016 |
The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinase Kinases; Animals; Antioxidants; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Down Syndrome; Female; Hippocampus; Male; Mice; Mitochondria; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Protein Kinases; Resveratrol | 2016 |
Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.
Topics: Acute-Phase Proteins; Animals; Antioxidants; Catechin; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Iron, Dietary; Lipocalin-2; Lipocalins; Mice, Inbred C57BL; Oncogene Proteins; Peroxidase; Proto-Oncogene Proteins; Tea | 2016 |
(-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase.
Topics: Animals; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Humans; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Organelle Biogenesis; Phosphorylation; RNA Interference; Signal Transduction; Transfection | 2016 |
Neurorestorative effects of epigallocatechin-3-Gallate on cognitive function in a chronic cerebral hypoperfusion rat model.
Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cerebrovascular Disorders; Cognition Disorders; Disease Models, Animal; Drug Administration Routes; Escape Reaction; Hippocampus; Male; Malondialdehyde; Maze Learning; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2016 |
(-)-Epigallocatechin-3-gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss.
Topics: Animals; Biomarkers; Caco-2 Cells; Catechin; Chemokine CCL2; Colitis, Ulcerative; Dextran Sulfate; Digestion; Disease Models, Animal; Humans; Intestinal Absorption; Male; Mice, Inbred Strains; Oxidative Stress; Permeability; Weight Loss | 2016 |
Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux.
Topics: Animals; Apoptosis; Autophagy; Cardiotonic Agents; Catechin; Creatine Kinase, MB Form; Disease Models, Animal; Hemodynamics; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases | 2016 |
Strong Inhibition of Secretory Sphingomyelinase by Catechins, Particularly by (-)-Epicatechin 3-O-Gallate and (-)-3'-O-Methylepigallocatechin 3-O-Gallate.
Topics: Animals; Atherosclerosis; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase | 2016 |
Chemical composition and anti-inflammatory activity of the leaves of Byrsonima verbascifolia.
Topics: Animals; Anti-Inflammatory Agents; Brazil; Catechin; Disease Models, Animal; Edema; Female; Flavonoids; Glycosides; Inflammation; Lipopolysaccharides; Macrophages; Male; Malpighiaceae; Mice, Inbred BALB C; Mice, Inbred Strains; Nitric Oxide; Phytotherapy; Plant Extracts; Plant Leaves; Triterpenes | 2016 |
Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome.
Topics: Animals; Catechin; Cytokines; Disease Models, Animal; Drug Synergism; Dry Eye Syndromes; Epithelial Cells; Epithelium, Corneal; Gene Expression Profiling; Humans; Hyaluronic Acid; Inflammation Mediators; Lubricant Eye Drops; Male; Rabbits | 2016 |
Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cytokines; Disease Models, Animal; Male; Metabolic Syndrome; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Prostatic Hyperplasia; Rats, Sprague-Dawley; Somatomedins | 2016 |
EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice.
Topics: Animals; Anticarcinogenic Agents; Benzodiazepinones; Biomarkers, Tumor; Carcinogenesis; Catechin; Dietary Supplements; Disease Models, Animal; Enzyme Activation; Epithelial-Mesenchymal Transition; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 7; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Random Allocation; Smoking; Stomach Neoplasms | 2016 |
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Topics: Animals; Catechin; Cognition; Disease Models, Animal; Down Syndrome; Female; Hippocampus; Male; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neocortex; Neural Pathways; Neurogenesis; Neuroprotective Agents; Synapses; Time Factors | 2016 |
Green tea (-)-epigallocatechin-3-gallate counteracts daytime overeating induced by high-fat diet in mice.
Topics: Animals; Antioxidants; Catechin; Diet, High-Fat; Disease Models, Animal; Feeding Behavior; Homeostasis; Hyperphagia; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Tea | 2016 |
Prevention of abdominal aortic aneurysm progression by oral administration of green tea polyphenol in a rat model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Calcium Chloride; Catechin; Collagen; Cytokines; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Elastin; Gene Expression Regulation; Inflammation Mediators; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Pancreatic Elastase; Phytotherapy; Plant Extracts; Plants, Medicinal; Polyphenols; Protein-Lysine 6-Oxidase; Rats, Sprague-Dawley; Tea; Time Factors; Tropoelastin | 2017 |
Procyanidin Promotes Translocation of Glucose Transporter 4 in Muscle of Mice through Activation of Insulin and AMPK Signaling Pathways.
Topics: AMP-Activated Protein Kinases; Animals; Anthocyanins; Biflavonoids; Catechin; Disease Models, Animal; Glucose; Glucose Transporter Type 4; Glucosides; Humans; Hyperglycemia; Insulin; Mice; Muscle, Skeletal; Proanthocyanidins; Signal Transduction | 2016 |
Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption.
Topics: Administration, Oral; Animals; Anterior Cruciate Ligament; Biflavonoids; Catechin; Cyclooxygenase 2; Diet; Dinoprostone; Disease Models, Animal; Female; Grape Seed Extract; Interleukin-1beta; Male; Mass Spectrometry; Matrix Metalloproteinase 13; Metabolome; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Olea; Osteoarthritis; Phenylethyl Alcohol; Proanthocyanidins; Rabbits; RNA, Messenger; Wounds and Injuries | 2016 |
Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice.
Topics: Animals; Catechin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress | 2016 |
Restoration of Mimecan Expression by Grape Seed Procyanidin B2 Through Regulation of Nuclear Factor-kappaB in Mice With Diabetic Nephropathy.
Topics: Albuminuria; Animals; Biflavonoids; Blotting, Western; Body Weight; Catechin; Cholesterol; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Glomerular Basement Membrane; Glycation End Products, Advanced; Grape Seed Extract; Intercellular Signaling Peptides and Proteins; Kidney Glomerulus; Mesangial Cells; Mice; NF-kappa B; Oxidative Stress; Proanthocyanidins; Triglycerides | 2016 |
Epigallocatechin-3-gallate protects against hepatic ischaemia-reperfusion injury by reducing oxidative stress and apoptotic cell death.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Catechin; Cytochromes c; Disease Models, Animal; Glutathione; Glutathione Disulfide; Inflammation; Injections, Intraperitoneal; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury | 2016 |
Procyanidins Mitigate Osteoarthritis Pathogenesis by, at Least in Part, Suppressing Vascular Endothelial Growth Factor Signaling.
Topics: Animals; Biflavonoids; Catechin; Cells, Cultured; Chondrocytes; Collagen Type II; Disease Models, Animal; Female; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Osteoarthritis; Osteoporosis; Proanthocyanidins; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke.
Topics: Angiogenesis Inducing Agents; Animals; Brain; Catechin; Disease Models, Animal; Flavonoids; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Neovascularization, Physiologic; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Protein Kinase Inhibitors; Random Allocation; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Epicatechin downregulates adipose tissue CCL19 expression and thereby ameliorates diet-induced obesity and insulin resistance.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Anti-Inflammatory Agents; Catechin; Chemokine CCL19; Coculture Techniques; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Insulin Resistance; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Obesity; Panniculitis; RAW 264.7 Cells; Time Factors | 2017 |
The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease.
Topics: Alkaloids; Allografts; Animals; Antioxidants; Benzodioxoles; Catechin; Disease Models, Animal; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Quercetin; T-Lymphocytes, Regulatory; Tea | 2017 |
Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Burns, Chemical; Catechin; Cell Survival; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Integrin alphaVbeta3; Mice, Inbred C57BL; Molecular Targeted Therapy; Nanoparticles; Oligopeptides; Ophthalmic Solutions | 2017 |
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Kinetics; Ligands; Male; Mice; Molecular Conformation; Molecular Targeted Therapy; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.
Topics: Animals; Catechin; Craniofacial Abnormalities; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Gene Dosage; Mice; Phenotype; Phosphorylation; Pregnancy; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2016 |
Regression of atherosclerosis with apple procyanidins by activating the ATP-binding cassette subfamily A member 1 in a rabbit model.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; ATP Binding Cassette Transporter 1; Biflavonoids; Cardiovascular Agents; Catechin; Cholesterol; Disease Models, Animal; Fruit; Lipoproteins, LDL; Male; Malus; Oxidative Stress; Phytotherapy; Plants, Medicinal; Plaque, Atherosclerotic; Proanthocyanidins; Reactive Oxygen Species; RNA, Messenger; Scavenger Receptors, Class E; Time Factors; Up-Regulation | 2017 |
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Drug Combinations; Interleukin-1beta; Leukotriene B4; Lipoxygenase Inhibitors; Male; Maze Learning; Memory; Mice, Transgenic; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; tau Proteins | 2017 |
A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer.
Topics: Acetylcysteine; Adenomatous Polyposis Coli; Animals; Antineoplastic Agents, Phytogenic; Camellia sinensis; Catechin; Cell Transformation, Neoplastic; Colorectal Neoplasms; Cycloheximide; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblast Growth Factor 2; Genes, APC; HCT116 Cells; HT29 Cells; Humans; Mice; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Time Factors; Transfection | 2008 |
Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury.
Topics: Administration, Oral; Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Drug Administration Schedule; Hemodynamics; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
Topics: Animals; Antimutagenic Agents; Arthritis; Blotting, Western; Catechin; Cell Differentiation; Disease Models, Animal; Down-Regulation; Gene Expression; Humans; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Catechin; Cells, Cultured; Cytokine Receptor gp130; Cytokines; Disease Models, Animal; Female; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-1beta; Interleukin-6; Matrix Metalloproteinase 2; Rats; Rats, Inbred Lew; Receptors, Interleukin-6; Synovial Membrane; Up-Regulation | 2008 |
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease.
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; Catechin; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Ki-67 Antigen; Lymphocytes; Mice; Mice, Inbred NOD; Phytotherapy; Proliferating Cell Nuclear Antigen; Sjogren's Syndrome; Submandibular Gland; Tea | 2008 |
Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice.
Topics: Animals; Catechin; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Serine; Tyrosine 3-Monooxygenase | 2009 |
Chemoprevention of fibroid tumors by [-]-epigallocatechin-3-gallate in quail.
Topics: Animals; Anticarcinogenic Agents; Bird Diseases; Catechin; Coturnix; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Oviducts; Random Allocation; Uterine Neoplasms | 2008 |
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
Topics: Angiogenesis Inhibitors; Animals; Catechin; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Mice; Mice, SCID; Microcirculation; Neovascularization, Pathologic; Tea; Vitamin E | 2009 |
EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Cardiomegaly; Catechin; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelins; Enzyme Inhibitors; Fibroblasts; Fibrosis; Hydroxyproline; Male; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transcription Factors | 2009 |
Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study.
Topics: Animals; Antioxidants; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Catechin; Dietary Supplements; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Gene Expression Regulation; Inflammation; Inflammation Mediators; Lipids; Liver; Male; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Serum Amyloid A Protein | 2009 |
An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Catechin; Cell Line, Tumor; Chemokine CCL2; Chemotaxis, Leukocyte; Cysteine-Rich Protein 61; Disease Models, Animal; Humans; Oncostatin M; Osteoblasts; Periapical Periodontitis; Plant Extracts; Rats; Rats, Wistar; Tea | 2009 |
Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Catalase; Catechin; Disease Models, Animal; DNA, Mitochondrial; Electron Transport Chain Complex Proteins; Enzyme Activation; Glutathione Peroxidase; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Malondialdehyde; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria, Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor AP-1 | 2009 |
Effects of Pithecellobium clypearia Benth extract and its main components on inflammation and allergy.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Benzopyrans; Carrageenan; Catechin; Croton Oil; Disease Models, Animal; Edema; Fabaceae; Histamine Antagonists; Hypersensitivity; Inflammation; Lipopolysaccharides; Liver; Male; Mast Cells; Mice; Molecular Structure; Plant Extracts; Plant Leaves; Plant Stems; Propionibacterium acnes; Rats | 2009 |
Effects of Pinus brutia bark extract and Pycnogenol in a rat model of carrageenan induced inflammation.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Flavonoids; Inflammation; Male; Phytotherapy; Pinus; Plant Bark; Plant Extracts; Quercetin; Rats; Rats, Wistar | 2009 |
Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism.
Topics: Animals; Brain; Carotenoids; Catechin; Disease Models, Animal; Glutathione; Huntington Disease; Lycopene; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats | 2009 |
Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence.
Topics: Animals; Antioxidants; Brucella abortus; Catalase; Catechin; Disease Models, Animal; Fatigue Syndrome, Chronic; Glutathione; Hyperalgesia; Lipid Peroxidation; Lipopolysaccharides; Locomotion; Mice; Mice, Inbred Strains; Nitrites; Oxidative Stress; Superoxide Dismutase; Swimming; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2009 |
Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate.
Topics: Aggrecans; Animals; Antioxidants; Cartilage, Articular; Catechin; Chondrocytes; Collagen Type II; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Gene Expression; Glycine max; Horses; Interleukin-1beta; NF-kappa B; Persea; Phenotype; Plant Extracts; Polymerase Chain Reaction; RNA; Tumor Necrosis Factor-alpha | 2010 |
Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.
Topics: Animals; Antioxidants; Behavior, Animal; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mitochondria; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar | 2009 |
Supplementary catechins attenuate cooking-oil-fumes-induced oxidative stress in rat lung.
Topics: Acute Lung Injury; Aldehydes; Animals; Apoptosis; bcl-2-Associated X Protein; Catechin; Cooking; Dietary Supplements; Disease Models, Animal; Female; HSP70 Heat-Shock Proteins; Oils; Oxidative Stress; Pneumonia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reactive Oxygen Species; Time Factors; Tyrosine | 2009 |
Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis.
Topics: Animals; Aorta, Thoracic; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Catechin; Diet, Atherogenic; Disease Models, Animal; Inflammation; Injections, Intraperitoneal; Lymphocyte Count; Male; Platelet Count; Rats; Rats, Wistar | 2010 |
Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy.
Topics: Acetylcysteine; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Catechin; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Glutathione; Hyperoxia; Hypoxia; Ischemia; Lipid Peroxidation; Metalloporphyrins; Mice; Mice, Inbred C57BL; Peroxynitrous Acid; Protective Agents; Retinal Neovascularization; Retinal Vessels; Tyrosine | 2010 |
The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Catechin; Cell Line; Chemokine CXCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophil Infiltration; Organ Size; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2010 |
(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.
Topics: Animals; Apoptosis; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Humans; JNK Mitogen-Activated Protein Kinases; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Paclitaxel | 2010 |
Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome.
Topics: Administration, Oral; Animals; Antioxidants; Brain; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fatigue Syndrome, Chronic; Mice; Oxidative Stress; Spleen; Swimming; Thymus Gland; Tumor Necrosis Factor-alpha | 2010 |
The antioxidant effect of green tea catechin ameliorates experimental liver injury.
Topics: Actins; Alanine Transaminase; Aldehydes; Animals; Antioxidants; Aspartate Aminotransferases; Camellia sinensis; Catechin; Cholestasis; Deoxyguanosine; Disease Models, Animal; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2010 |
Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biflavonoids; Biomarkers; Catechin; Chlorogenic Acid; Cholesterol; Diet; Dioxoles; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; F2-Isoprostanes; Fatty Acids; Flavonoids; Heme Oxygenase-1; Inflammation; Leukotriene B4; Lignans; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; P-Selectin; Phenols; Polyphenols; Quercetin; Superoxides | 2010 |
Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
Topics: Animals; Antioxidants; Catechin; Cell Line; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Indans; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Neuroprotective Agents; Parkinsonian Disorders; Recovery of Function; Substantia Nigra; Treatment Outcome | 2010 |
Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis.
Topics: Aging; Animals; Antioxidants; Apolipoproteins B; Atherosclerosis; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Reactive Oxygen Species; Receptors, LDL; Superoxides | 2010 |
The functional effect of epigallocatechin gallate on ischemic stroke in rats.
Topics: Animals; Behavior, Animal; Brain Infarction; Catechin; Disease Models, Animal; Hindlimb; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sensory Gating; Statistics, Nonparametric | 2010 |
Epigallocatechin-3-gallate ameliorates hyperglycemia-induced embryonic vasculopathy and malformation by inhibition of Foxo3a activation.
Topics: Animals; Antioxidants; Blotting, Western; Catechin; Disease Models, Animal; Embryonic Development; Female; Fetus; Forkhead Box Protein O3; Forkhead Transcription Factors; Hyperglycemia; In Vitro Techniques; Oxidative Stress; Phosphorylation; Pregnancy; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Yolk Sac | 2010 |
Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats.
Topics: Animals; Catechin; Cell Count; Cell Survival; Disease Models, Animal; Female; Nerve Crush; Neurofilament Proteins; Neuroprotective Agents; Optic Nerve Injuries; Random Allocation; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells; Time Factors; Treatment Outcome | 2010 |
Antioxidant, antimutagenic, and antidiabetic activities of edible leaves from Cnidoscolus chayamansa Mc. Vaugh.
Topics: Animals; Antimutagenic Agents; Antioxidants; Catechin; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Disease Models, Animal; Euphorbiaceae; Flavonoids; Gallic Acid; Hydroxybenzoates; Hypoglycemic Agents; Mutagenicity Tests; Phenols; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Rutin | 2010 |
Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Topics: Animals; Catechin; Cell Death; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nitric Oxide Synthase Type II; Parkinsonian Disorders; Tea | 2010 |
Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion.
Topics: Administration, Oral; Analysis of Variance; Animals; Catechin; Coronary Circulation; Coronary Occlusion; Disease Models, Animal; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Probability; Radiography; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Survival Rate; Treatment Outcome; Ventricular Remodeling | 2010 |
(-)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects.
Topics: Animals; Anxiety; Caffeine; Catechin; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Male; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Rats; Rats, Wistar; Spectrum Analysis | 2010 |
Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Catechin; Chronic Disease; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Male; Prostate; Prostatitis; Rats; Rats, Wistar | 2011 |
Amelioration of functional, biochemical and molecular deficits by epigallocatechin gallate in experimental model of alcoholic neuropathy.
Topics: Alcoholic Neuropathy; Analysis of Variance; Animals; Behavior, Animal; Catechin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hyperalgesia; Male; Oxidative Stress; Physical Stimulation; Rats; Rats, Wistar; Urokinase-Type Plasminogen Activator | 2011 |
[Protective activity of different concentration of tea polyphenols and its major compound EGCG against whole body irradiation-induced injury in mice].
Topics: Animals; Camellia sinensis; Catechin; Disease Models, Animal; Female; Flavonoids; Humans; Male; Mice; Phenols; Plant Extracts; Polyphenols; Radiation Injuries; Radiation-Protective Agents; Random Allocation; Superoxide Dismutase; Whole-Body Irradiation | 2010 |
Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; bcl-2-Associated X Protein; Catechin; Chronic Disease; Diet; Disease Models, Animal; Estradiol; Glycine max; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Isoflavones; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Rats; Signal Transduction; Soy Foods; Tea; Testosterone; Tumor Necrosis Factor-alpha | 2011 |
EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP.
Topics: ADAM Proteins; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Catechin; Cell Line; Disease Models, Animal; Estrogen Receptor alpha; Female; Furin; Humans; Membrane Proteins; Mice; Models, Biological; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction | 2010 |
Supplementation of green tea catechins in dentifrices suppresses gingival oxidative stress and periodontal inflammation.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Camellia sinensis; Catechin; Connective Tissue; Dentifrices; Disease Models, Animal; Epithelial Attachment; Gingiva; Gingival Recession; Lipid Peroxidation; Lysine; Male; NF-kappa B; Oxidative Stress; Periodontitis; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Tyrosine | 2011 |
Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.
Topics: Acute Disease; Animals; Arachidonate 5-Lipoxygenase; Catechin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Combinations; Gene Expression Regulation; Inflammation; Lipoxygenase Inhibitors; Male; Pancreatitis; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley | 2010 |
Biological actions of green tea catechins on cardiac troponin C.
Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Hypertrophic; Catechin; Disease Models, Animal; Humans; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Quartz Crystal Microbalance Techniques; Rabbits; Stereoisomerism; Tea; Troponin C | 2010 |
Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury.
Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Male; Myocytes, Cardiac; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2011 |
Antinociceptive effect on mice of the hydroalcoholic fraction and (-) epicatechin obtained from Combretum leprosum Mart & Eich.
Topics: Acute Disease; Analgesics; Animals; Catechin; Combretum; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Male; Mice; Pain; Pain Measurement; Plant Extracts | 2010 |
Down-regulation of NF-κB signalling by polyphenolic compounds prevents endotoxin-induced liver injury in a rat model.
Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Endotoxins; Female; Humans; Liver Diseases; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Polyphenols; Quercetin; Rats; Rats, Wistar; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Camellia sinensis; Catechin; Cell Line, Tumor; Dacarbazine; Disease Models, Animal; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Glioblastoma; Humans; Immunohistochemistry; Mice; Mice, Knockout; Temozolomide | 2011 |
Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment.
Topics: Animals; Binding Sites; Catechin; Cell Migration Inhibition; Cells, Cultured; Chemokine CXCL10; Chemokine CXCL11; Chemokine CXCL9; Chemokines; Disease Models, Animal; Inflammation Mediators; Lung; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Mice, Transgenic | 2011 |
Polyphenols from Parabarium huaitingii and their positive inotropic and anti-myocardial infarction effects in rats.
Topics: Animals; Apocynaceae; Calcium; Cardiotonic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Medicine, Chinese Traditional; Myocardial Contraction; Myocardial Infarction; Plant Extracts; Plant Stems; Plants, Medicinal; Proanthocyanidins; Prohibitins; Random Allocation; Rats; Rats, Wistar; Stimulation, Chemical | 2011 |
Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Catechin; Disease Models, Animal; Gastric Mucosa; Indomethacin; Lipid Peroxidation; Male; Mice; Omeprazole; Oxidative Stress; Stomach Ulcer; Tea | 2011 |
Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Folic Acid; Gastrointestinal Neoplasms; Hematinics; Male; Methylnitronitrosoguanidine; Rats; Rats, Wistar; Sarcoma; Treatment Outcome | 2011 |
Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model.
Topics: Alcohols; Animals; Antioxidants; Catechin; Cell Nucleus; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endotoxins; Female; Liver; Malondialdehyde; NF-kappa B; Nitrites; Rats; Rats, Wistar; Signal Transduction; Tumor Necrosis Factor-alpha | 2011 |
A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model.
Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Mitomycin; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 2011 |
Phytotherapy in a rat model of hyperoxaluria: the antioxidant effects of quercetin involve serum paraoxonase 1 activation.
Topics: Animals; Antioxidants; Apolipoprotein A-I; Aryldialkylphosphatase; Blotting, Western; Catechin; Cholesterol, HDL; Clusterin; Disease Models, Animal; Enzyme Activation; Ethylene Glycol; Hyperoxaluria; Male; Oxidative Stress; Phytotherapy; Plant Preparations; Quercetin; Rats; Rats, Wistar; Renal Insufficiency | 2011 |
Catechins attenuate eccentric exercise-induced inflammation and loss of force production in muscle in senescence-accelerated mice.
Topics: Aging, Premature; Alanine Transaminase; Animals; Aspartate Aminotransferases; Calcium-Transporting ATPases; Catechin; Chemokine CCL2; Disease Models, Animal; Glutathione; Glutathione Disulfide; Inflammation; Interleukin-6; Male; Malondialdehyde; Mice; Muscle Contraction; Muscle, Skeletal; Oxidative Stress; Physical Endurance; Running; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha | 2011 |
Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice.
Topics: Animals; Blood Glucose; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Polyphenols | 2011 |
Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing.
Topics: Adenocarcinoma; Animals; Catechin; Clusterin; Disease Models, Animal; Endoplasmic Reticulum; Golgi Apparatus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Protein Processing, Post-Translational; Tea | 2011 |
Effects of topical application of EGCG on testosterone-induced hair loss in a mouse model.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Alopecia; Animals; Antioxidants; Apoptosis; Catechin; Cyproterone Acetate; Dihydrotestosterone; Disease Models, Animal; Down-Regulation; Epithelial Cells; Female; Hair; Hair Follicle; Mice; Mice, Inbred CBA; Receptors, Androgen; Sebaceous Glands; Testosterone | 2011 |
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Topics: Animals; Antioxidants; Catechin; Chemokines; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Immunohistochemistry; Interleukin-1beta; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D | 2011 |
Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model.
Topics: Animals; Catechin; Disease Models, Animal; Female; Menopause; Neuroprotective Agents; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Tea; Urinary Bladder, Overactive | 2012 |
Antiosteoporotic activity of Davallia formosana.
Topics: Alendronate; Alkaline Phosphatase; Amino Acids; Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Catechin; Cell Differentiation; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Femur; Mice; Osteoclasts; Osteoporosis; Ovariectomy; Plant Extracts; Plants, Medicinal; Polypodiaceae; RANK Ligand; Rats; Rats, Wistar; Rhizome; Solvents; Time Factors; X-Ray Microtomography | 2012 |
Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cacao; Carcinoma, Pancreatic Ductal; Catechin; Cell Cycle Checkpoints; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Genes, ras; Humans; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Polyphenols; Proto-Oncogene Proteins c-akt; Tandem Mass Spectrometry; Transcription, Genetic | 2012 |
Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models.
Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus; Disease Models, Animal; Fatty Acids; Fatty Liver; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Liver Function Tests; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Pinus; Plant Bark; Plant Extracts; Proanthocyanidins; RNA, Messenger; Tomography, X-Ray Computed | 2012 |
Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model.
Topics: Animals; Arginine; Catechin; Disease Models, Animal; Extremities; Hyperalgesia; Injections, Spinal; Ligation; Male; Neuralgia; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves | 2012 |
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Topics: Amyloid; Amyloid Neuropathies, Familial; Animals; Biomarkers; Catechin; Colon; Disease Models, Animal; Endoplasmic Reticulum Stress; Gastric Mucosa; Humans; Mice; Mice, Transgenic; Peripheral Nervous System; Prealbumin; Stomach | 2012 |
Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow.
Topics: Animals; Antioxidants; Apolipoproteins B; Biomechanical Phenomena; Catechin; Cerebral Arteries; Cerebrovascular Circulation; Compliance; Disease Models, Animal; Dyslipidemias; Endothelium, Vascular; Enzyme Precursors; Genotype; Humans; Intracranial Arteriosclerosis; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phenotype; Receptors, LDL; Severity of Illness Index; Stress, Mechanical; Tomography, Optical Coherence; Vasodilation | 2012 |
Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea.
Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Eating; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Oxidative Stress; Polyphenols; Tea | 2012 |
Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis.
Topics: Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Catechin; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Drug Combinations; Extracellular Signal-Regulated MAP Kinases; Intracellular Signaling Peptides and Proteins; Leukotriene B4; Lipoxins; Lipoxygenase Inhibitors; Liver; Lung; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Sepsis | 2012 |
Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model.
Topics: Animals; Apoptosis; Biflavonoids; Cartilage, Articular; Catechin; Cell Differentiation; Chondrocytes; Disease Models, Animal; Knee Joint; Male; Mice; Nitric Oxide Synthase Type I; Ossification, Heterotopic; Osteoarthritis, Knee; Proanthocyanidins | 2012 |
Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Biflavonoids; Blotting, Western; Catechin; Disease Models, Animal; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Vesicular Monoamine Transport Proteins | 2012 |
Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model.
Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Female; Menopause; Ovariectomy; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Urinary Bladder, Overactive | 2012 |
Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model.
Topics: Alanine Transaminase; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Catechin; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Enalapril; Endothelin-1; Fibronectins; Lipid Peroxidation; Male; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 2012 |
Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Biflavonoids; Catechin; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dyskinesias; Encephalitis; Glial Fibrillary Acidic Protein; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Probenecid; Proto-Oncogene Proteins c-bcl-2; Reaction Time | 2013 |
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss | 2012 |
Beneficial effects of (-)-epigallocatechin gallate on ischemia-reperfusion testicular injury in rats.
Topics: Animals; Antioxidants; Biomarkers; Catechin; Disease Models, Animal; Male; Postoperative Complications; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Spermatic Cord Torsion | 2012 |
A modulating effect of epigallocatechin gallate (EGCG), a tea catechin, on the bladder of rats exposed to water avoidance stress.
Topics: Animals; Catechin; Cell Degranulation; Cystitis, Interstitial; Defecation; Disease Models, Animal; Female; Immersion; Injections, Intraperitoneal; Mast Cells; Rats; Rats, Sprague-Dawley; Stress, Psychological; Time Factors; Urinary Bladder; Urination; Water | 2013 |
Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset.
Topics: Animals; Antibodies, Antinuclear; Antioxidants; Catechin; Disease Models, Animal; DNA Repair; Exocrine Glands; Female; Lymphocytes; Mice; Mice, Inbred NOD; Peroxiredoxin VI; Proliferating Cell Nuclear Antigen; Sjogren's Syndrome; Time Factors | 2012 |
Diverse mechanisms of antidiabetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice.
Topics: Animals; Biflavonoids; Blood Glucose; Catechin; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Hypoglycemic Agents; Male; Mice; Phytotherapy; Plant Extracts; Proanthocyanidins | 2012 |
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
Topics: Animals; Antioxidants; Catechin; Cells, Cultured; Cisplatin; Cytochromes c; Disease Models, Animal; HeLa Cells; Humans; In Vitro Techniques; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Succinate Dehydrogenase | 2012 |
Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Behavior, Animal; Catechin; Cells, Cultured; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Inflammation; Lipopolysaccharides; Male; Memory Disorders; Mice; Mice, Inbred ICR; Neurons; Nitric Oxide Synthase Type II; Peptide Fragments; Rats | 2013 |
Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats.
Topics: Actins; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Ethanol; gamma-Glutamyltransferase; Genistein; Liver Cirrhosis; Peroxidase; Proto-Oncogene Proteins c-bcl-2; Rats; RNA, Messenger; Smad3 Protein; Taurine | 2012 |
Natural therapies assessment for the treatment of endometriosis.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Injections, Intraperitoneal; Intestinal Diseases; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Resveratrol; Stilbenes | 2013 |
Green tea extract reverses endothelial dysfunction and reduces atherosclerosis progression in homozygous knockout low-density lipoprotein receptor mice.
Topics: Alanine Transaminase; Animals; Antioxidants; Aorta; Atherosclerosis; Biomarkers; Catechin; Chemokine CCL2; Disease Models, Animal; Endothelium, Vascular; Female; Inflammation; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plant Extracts; Receptors, LDL; Tea; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast.
Topics: Animals; Catechin; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Fibroblasts; Fibronectins; Fibrosis; Gene Expression Regulation, Neoplastic; Humans; Male; Myocardium; NF-kappa B; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea | 2013 |
Neuroprotective effect of (-)-epigallocatechin-3-gallate in rats when administered pre- or post-traumatic brain injury.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Brain Edema; Brain Injuries; Catechin; Deoxyguanosine; Disease Models, Animal; DNA, Single-Stranded; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Lipid Peroxidation; Male; Maze Learning; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Time Factors | 2013 |
Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antiparkinson Agents; Carbidopa; Catechin; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Disease Models, Animal; Excitatory Amino Acid Agonists; Fluoresceins; Glial Fibrillary Acidic Protein; Hippocampus; Hydroxybenzoates; In Vitro Techniques; Kainic Acid; Levodopa; Male; Methylation; Mice; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Reserpine; Time Factors; Tyrosine | 2013 |
(-) Epicatechin attenuates mitochondrial damage by enhancing mitochondrial multi-marker enzymes, adenosine triphosphate and lowering calcium in isoproterenol induced myocardial infarcted rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Biomarkers; Calcium; Catechin; Citric Acid Cycle; Creatine Kinase; Disease Models, Animal; Electron Transport Complex IV; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hydroxyl Radical; Isocitrates; Isoproterenol; Ketoglutaric Acids; L-Lactate Dehydrogenase; Lipid Peroxidation; Malates; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Infarction; NADH Dehydrogenase; Rats; Rats, Wistar; Succinic Acid; Superoxide Dismutase; Troponin I | 2013 |
Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells.
Topics: Animals; Catechin; Cells, Cultured; Child; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; Humans; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred A; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Myeloid Cells; Neuroblastoma; Receptors, Laminin; Survival Rate; T-Lymphocytes; Tea | 2013 |
Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy.
Topics: Acute Kidney Injury; Animals; Antioxidants; Catechin; Disease Models, Animal; Glutathione; Glutathione Disulfide; Humans; Infusions, Parenteral; Kidney; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction | 2013 |
Green tea and prostate cancer.
Topics: Animals; Apoptosis; Catechin; Chemoprevention; Disease Models, Animal; Forecasting; Humans; Male; Mice; Phytotherapy; Prostatic Neoplasms; Receptors, Androgen; Tea | 2002 |
Cocoa extract protects against early alcohol-induced liver injury in the rat.
Topics: Alanine Transaminase; Aldehydes; Animals; Cacao; Catechin; Celiac Disease; Disease Models, Animal; Enteral Nutrition; Ethanol; Inflammation; Liver Diseases, Alcoholic; Necrosis; Phytotherapy; Plant Extracts; Proteins; Rats; Weight Gain | 2002 |
Lack of inhibitory effects of green tea catechins in 1,2-dimetylhydrazine-induced rat intestinal carcinogenesis model: comparison of the different formulations, administration routes and doses.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Carcinogenicity Tests; Carcinogens; Catechin; Disease Models, Animal; Drug Administration Routes; Intestinal Neoplasms; Intestine, Large; Intestine, Small; Male; Rats; Rats, Inbred F344; Tea | 2002 |
Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2002 |
Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Camellia sinensis; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Phytotherapy; Plant Leaves; Plant Preparations; Rats; Rats, Wistar; Tea; Treatment Outcome; Urinary Bladder Neoplasms | 2003 |
Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils.
Topics: Animals; Antioxidants; Brain Chemistry; Catechin; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Flavonoids; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Phenols; Polyamines; Polymers; Prosencephalon; Time Factors | 2003 |
Epigallocatechin gallate can significantly decrease free oxygen radicals in the reperfusion injury in vivo.
Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Femoral Artery; Femoral Vein; Kinetics; Male; Muscle, Skeletal; Rats; Rats, Wistar; Reperfusion Injury; Superoxides | 2003 |
(-)-Epicatechin 3-O-gallate ameliorates the damages related to peroxynitrite production by mechanisms distinct from those of other free radical inhibitors.
Topics: Animals; Azoles; Blood Urea Nitrogen; Catechin; Copper; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Isoindoles; Japan; Kidney; Lipopolysaccharides; Lysine; Male; Nitric Oxide; Organoselenium Compounds; Peroxidase; Phytotherapy; Plant Extracts; Plant Roots; Proteinuria; Rats; Rats, Wistar; Reperfusion Injury; Rheum; Superoxide Dismutase; Tyrosine; Uric Acid; Zinc | 2004 |
Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
Topics: Allopurinol; Animals; Antioxidants; Biflavonoids; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Liver; Male; Mice; Mice, Inbred ICR; Oxonic Acid; Proanthocyanidins; Seeds; Time Factors; Urate Oxidase; Uric Acid; Vitis; Xanthine Dehydrogenase; Xanthine Oxidase | 2004 |
Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats.
Topics: Animals; Arginase; Blotting, Western; Catechin; Cicatrix; Cyclooxygenase 2; Disease Models, Animal; Injections, Intradermal; Isoenzymes; Male; Neovascularization, Physiologic; Nitric Oxide Synthase; Nitrites; Prostaglandin-Endoperoxide Synthases; Protease Inhibitors; Proteins; Rats; Rats, Sprague-Dawley; Time Factors; Vascular Endothelial Growth Factor A; Wound Healing | 2004 |
Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Biflavonoids; Catechin; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Muscle Fibers, Skeletal; Proanthocyanidins; Rats; Rats, Wistar; Seeds; Vitis | 2004 |
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Topics: Animals; Animals, Genetically Modified; Anticarcinogenic Agents; Catechin; Clusterin; Disease Models, Animal; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Tea | 2004 |
Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Mice; Neoplasm Invasiveness; Prostatic Neoplasms; Tea | 2004 |
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Apomorphine; Catechin; Disease Models, Animal; Free Radicals; Iron; Iron Chelating Agents; Lewy Bodies; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Substantia Nigra; Synucleins; Ubiquitin | 2004 |
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Energy Intake; Energy Metabolism; Fatty Liver; Hepatocytes; Liver; Liver Circulation; Male; Mice; Mice, Obese; Necrosis; Reperfusion Injury | 2005 |
Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Catechin; Cricetinae; Disease Models, Animal; Hypercholesterolemia; Male; Mesocricetus; Quercetin; Resveratrol; Stilbenes; Wine | 2005 |
Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice.
Topics: Animals; Brain; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fatigue Syndrome, Chronic; Flavonoids; Glutathione; Injections, Intraperitoneal; Lipid Peroxidation; Male; Mice; Oxidative Stress; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Tea | 2005 |
Animal models and analytical approaches for understanding the relationships between wine and cancer.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Catechin; Disease Models, Animal; DNA Adducts; Dose-Response Relationship, Drug; Human T-lymphotropic virus 1; Humans; Imidazoles; Liver Function Tests; Male; Mice; Mice, Transgenic; Neurofibromatoses; Quercetin; Rats; Rats, Inbred F344; Vitis; Wine | 2005 |
Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
Topics: Animals; Anti-Infective Agents; Catechin; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Follow-Up Studies; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Wistar; Treatment Outcome; Urine | 2005 |
Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ.
Topics: Animals; Animals, Newborn; Anticarcinogenic Agents; Apoptosis; Benzo(a)pyrene; Biflavonoids; Carcinoma in Situ; Catechin; Cell Proliferation; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Hyperplasia; Lung; Lung Neoplasms; Male; Mice; Plant Extracts; Proto-Oncogene Proteins; Proto-Oncogenes; Tea | 2005 |
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling.
Topics: Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; DNA Primers; Gene Expression Profiling; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prognosis; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tea | 2006 |
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Caspase 3; Caspases; Catechin; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Transgenic; Motor Activity; Mutation; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.
Topics: Animals; Antioxidants; Camellia sinensis; Catechin; Diet; Disease Models, Animal; Free Radical Scavengers; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Pentoxifylline; Phytotherapy; Plant Extracts; Plant Preparations | 2006 |
The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo.
Topics: Amyloid beta-Protein Precursor; Animals; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phytotherapy; Plant Preparations; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea | 2007 |
Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Catechin; Disease Models, Animal; Gene Expression Regulation; Inflammation; Interleukin-5; Matrix Metalloproteinase 9; Mice; Reactive Oxygen Species; Respiratory System; Toluene 2,4-Diisocyanate; Tumor Necrosis Factor-alpha | 2006 |
Epigallocatechin-3-gallate reduces allergen-induced asthma-like reaction in sensitized guinea pigs.
Topics: Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Catechin; Disease Models, Animal; Guinea Pigs; Lung; Male; Nitric Oxide Synthase; Ovalbumin | 2006 |
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins E; Atherosclerosis; Caffeic Acids; Cardiovascular Agents; Catechin; Cytokines; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Gene Expression; Mice; Mice, Knockout; Receptors, Chemokine; RNA, Messenger; Stilbenes | 2007 |
Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).
Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Carbolines; Catechin; Cells, Cultured; Chlordiazepoxide; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Electroshock; Embryo, Mammalian; gamma-Aminobutyric Acid; Hippocampus; Male; Maze Learning; Membrane Potentials; Mice; Neurons; Patch-Clamp Techniques; Reaction Time | 2006 |
Wine constituents inhibit thrombosis but not atherogenesis in C57BL/6 apolipoprotein E-deficient mice.
Topics: Animals; Antioxidants; Aortic Valve Stenosis; Apolipoproteins E; Atherosclerosis; Catechin; Diet; Disease Models, Animal; Eating; Ethanol; Flavonoids; Genetic Predisposition to Disease; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Phenols; Polyphenols; Thrombosis; Weight Gain; Wine | 2006 |
Polyphenol (-)-epigallocatechin gallate protection from ischemia/reperfusion-induced renal injury in normotensive and hypertensive rats.
Topics: Animals; Blood Urea Nitrogen; Catechin; Creatinine; Disease Models, Animal; Flavonoids; Hypertension; Phenols; Polyphenols; Rats; Rats, Inbred SHR; Reference Values; Renal Circulation; Reperfusion Injury | 2006 |
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Caspase 3; Catechin; Disease Models, Animal; Enzyme Activation; Female; Immunohistochemistry; Male; Mice; Mice, Transgenic; Microglia; Motor Neurons; Neuroprotective Agents; NF-kappa B | 2006 |
Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets.
Topics: Adult; Animals; Antioxidants; Atherosclerosis; Cacao; Catechin; Cricetinae; Diet; Disease Models, Animal; Europe; Female; Humans; Lipid Peroxidation; Lipids; Male; Mesocricetus; Middle Aged; Phenols; United States | 2006 |
Protective effects of EGCg or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts.
Topics: Animals; Antioxidants; Apoptosis; Calcium; Caspase 3; Catechin; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Female; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Perfusion; Reactive Oxygen Species | 2007 |
Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity.
Topics: Animals; Autoimmunity; Catechin; Cell Line; Cell Survival; Disease Models, Animal; Flavonoids; Humans; Imidazoles; Lymphocytes; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; Mice; Mice, Inbred NOD; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Plant Extracts; Polyphenols; Pyridines; Salivary Glands; Sjogren's Syndrome; Tea; Tumor Necrosis Factor-alpha | 2007 |
Nutrient mixture including vitamin C, L-lysine, L-proline, and epigallocatechin is ineffective against tumor growth and metastasis in a syngeneic neuroblastoma model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Catechin; Dietary Supplements; Disease Models, Animal; Female; Liver Neoplasms, Experimental; Lysine; Mice; Mice, Inbred A; Neuroblastoma; Proline | 2008 |
Combined treatment with green tea catechins and sodium nitrite selectively promotes rat forestomach carcinogenesis after initiation with N-methyl-N'- nitro-N-nitrosoguanidine.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Catechin; Deoxyguanosine; Disease Models, Animal; Epithelial Cells; Hyperplasia; Male; Methylnitronitrosoguanidine; Rats; Rats, Inbred F344; Stomach Neoplasms; Tea | 2007 |
Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis.
Topics: Animals; Beverages; Carbon Tetrachloride Poisoning; Catechin; Cell Culture Techniques; Disease Models, Animal; Disease Progression; Enzyme Activation; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2007 |
The green tea polyphenol epigallocatechin-3-gallate improves systemic hemodynamics and survival in rodent models of polymicrobial sepsis.
Topics: Animals; Blood Pressure; Catechin; Disease Models, Animal; Gene Expression; Lung; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Sprague-Dawley; Sepsis; Survival Rate | 2007 |
Modulation of infection-induced inflammation and locomotive deficit and longevity in senescence-accelerated mice-prone (SAMP8) model by the oligomerized polyphenol Oligonol.
Topics: Aging; Alzheimer Disease; Animals; Behavior, Animal; Catechin; Dietary Supplements; Disease Models, Animal; Eye; Female; Inflammation; Longevity; Male; Mice; Mice, Inbred Strains; Motor Activity; Parasitic Diseases, Animal; Parkinson Disease; Phenols; Survival Rate; Time Factors; Virus Diseases | 2007 |
Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Catechin; Cell Death; Disease Models, Animal; Flavonoids; Hippocampus; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Quercetin; Rats; Rats, Wistar; Rutin; Space Perception; Structure-Activity Relationship | 2007 |
Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
Topics: Animals; Antioxidants; Catechin; Chagas Disease; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Hepatocytes; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Parasitemia; Random Allocation; Trypanocidal Agents; Trypanosoma cruzi | 2007 |
Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
Topics: Animals; Antioxidants; Catechin; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Liver; Male; Rats; Rats, Sprague-Dawley | 2008 |
Protective effect of (+)-catechin against gastric mucosal injury induced by ischaemia-reperfusion in rats.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Antioxidants; Catalase; Catechin; Corticosterone; Disease Models, Animal; Flavonoids; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Lipid Peroxidation; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stomach Ulcer; Superoxide Dismutase | 2007 |
Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.
Topics: Animals; Antioxidants; Catechin; Colitis; Cytokines; Disease Models, Animal; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; Peroxidase; Tea; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid | 2008 |
[Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis].
Topics: Animals; Blotting, Western; Catechin; Cyclooxygenase 2; Disease Models, Animal; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trinitrobenzenesulfonic Acid | 2007 |
Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia.
Topics: Animals; Catechin; Cognition; Disease Models, Animal; Hippocampus; Hypoxia; Lipid Peroxidation; Male; Maze Learning; NADPH Oxidases; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Sleep Apnea Syndromes; Tea | 2008 |
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats.
Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Subcellular Fractions; Time Factors | 2008 |
The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.
Topics: Alzheimer Disease; Animals; Catechin; Disease Models, Animal; Male; Maze Learning; Psychomotor Performance; Rats; Rats, Wistar | 2007 |
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Catechin; Cognition Disorders; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Maze Learning; Mice; Mice, Transgenic; Mutation; Neuroprotective Agents; Phosphorylation; tau Proteins | 2008 |
[Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
Topics: Animals; Benzopyrans; Catechin; Chlorobenzenes; Disease Models, Animal; Flavonoids; Hexachlorobenzene; Liver Diseases; Porphyrias; Rats; Research Design; Silymarin | 1982 |
Effects of green tea catechins in a rat multi-organ carcinogenesis model.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Catechin; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Intestinal Neoplasms; Intestine, Small; Kidney Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Models, Biological; Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1993 |
Prevention of doxorubicin induced cardiotoxicity by catechin.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Catechin; Depression, Chemical; Disease Models, Animal; Doxorubicin; Electrocardiography; Heart Diseases; Male; Microscopy, Electron; Myocardial Contraction; Rats; Rats, Sprague-Dawley | 1996 |
Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters.
Topics: Animals; Aorta; Arteriosclerosis; Catechin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Diet; Dietary Fats, Unsaturated; Disease Models, Animal; Eating; Growth; Hypercholesterolemia; Male; Olive Oil; Plant Oils; Vitamin E | 1998 |
Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
Topics: Animals; Anti-Bacterial Agents; Catechin; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Female; Male; Mice; Tea | 1998 |
Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Catechin; Cell Line; Disease Models, Animal; Down-Regulation; Flavonoids; Gene Expression Regulation; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Phenols; Polymers; Tea; Tumor Necrosis Factor-alpha | 1998 |
Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Male; Papilloma; Rats; Rats, Wistar; Tea; Urinary Bladder Neoplasms | 1999 |
[Studies on the effects of tea catechins against hepatitis B virus infection].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Catechin; Disease Models, Animal; DNA, Viral; Ducks; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Tea | 2001 |
The protective effect of catechin on gastric mucosal lesions in rats, and its hormonal mechanisms.
Topics: Animals; Catechin; Disease Models, Animal; Gastric Mucosa; Gastrins; Male; Rats; Rats, Wistar; Somatostatin; Stomach Diseases | 2002 |
The protective activity of tea catechins against experimental infection by Vibrio cholerae O1.
Topics: Animals; Body Fluids; Catechin; Cholera; Cholera Toxin; Disease Models, Animal; Intestines; Male; Mice; Mice, Inbred C57BL; Rabbits; Tea | 1992 |
Protease inhibitors prevent the development of human rotavirus-induced diarrhea in suckling mice.
Topics: Administration, Oral; Animals; Animals, Suckling; Aprotinin; Catechin; Cysteine Proteinase Inhibitors; Diarrhea; Disease Models, Animal; Flavonoids; Intestine, Small; Mice; Mice, Inbred BALB C; Protease Inhibitors; Rotavirus; Rotavirus Infections; Serine Proteinase Inhibitors | 1991 |